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ABSTRACT 
This thesis comprises of five chapters. In the first chapter a 
general literature review of the subject matter with selected references 
the illuminate the deeds of antiquity by the ancient scholars and 
philosophers has been described. Early advances in medicinal chemistry 
were concerned with the estimation, isolation and structural 
determination of medicinal agents of natural origin. The modern period 
witnessed discovery and subsequent synthesis of miracle drugs. 
Advances In sophisticated methods of structural analysis including 
spectroscopy radioimmunoassay, chromatography etc, helped to study 
minute amounts of compounds (upto i-ig-ng levels). Establishment of 
regulatory bodies (e.g. Food and Drug Administration) forced 
pharmaceutical industries to improve their analytical, chemical, and 
bloassay procedures which helped In development, production and 
marketing of medicinal agents. Reliability and reproducibility of an 
analytical procedure Is determined by method validation. Overall 
method validation strategy has been discussed. Various statistical 
parameters examined by method validation have been illustrated. 
Drugs may contain impurities resulting from raw materials and 
reagents, as reaction by-products and through degradation during 
manufacture and storage. The classification of such impurities has been 
discussed. Importance of analytical chemistry, particularly in the field of 
pharmaceutical analysis and its role in testing the medicine before it is 
made available to the public has been elaborated. Various analytical 
techniques used in determination of drugs in bulk and dosage forms 
have also been reviewed. 
The role of physico-analytical and organic chemistry, in drug 
designing and structural reactivity of these drugs, are worth to be 
mentioned. Classification of drugs based on pharmacological and 
chemical properties has been discussed. A brief description of 
antibiotics with special references to penicillins, cephalosporins, 
chloramphenicol and aminoglycosides is included. Different methods of 
analysis of these antibiotics have also been highlighted. 
Second chapter describes simultaneous volumetric and 
spectrophotometric method for determination of penicillins (ampicillin, 
amoxycillin and carbenicillin). In this method penicillins are hydrolysed 
in the presence of aqueous solution of diethylamine (pH~ 12.25) at 
80 ± 2^C. The degraded hydrolyzed products are acidified with dilute 
hydrochloric acid (pH ~ 1.4) followed by titration with potassium 
iodate. The liberated free iodine gives deep red-violet colour in the non-
aqueous layer at the end point. For spectrophotometric determination 
the extracted coloured layer is separated and detected at 520nm. The 
mechanism of degraded products has been discussed in the light of 
various studies e.g. TLC, IP. and molar stolchimetric ratio. The reaction 
involved at the equivalence point is summarized as, 
210^ • 12H' <- lOe" -V I2 +6H2O E° = 1.19V 
Beer's law limit and apparent molar absorptivity has been 
reported. The method has been successfully applied to the 
determination of ampicillin, amoxycillin and carbenicillin in pure form 
and in pharmaceutical formulations. The results obtained by both the 
recomimended method and the reference method were in good 
agreement. Statistical treatment of the analytical data has been 
reported. Effect of common excipients used in the manufacture of 
drugs was studied. 
In chapter three, spectrophotometric method for determination 
of penicillins (ampicillin, amoxicillin and carbenicillin) using Folin -
Ciocalteu phenol reagent has been discussed. In this method reaction 
mixture of penicillin and Folin-Ciocalteu reagent (pH 2.25) is heated In 
a thermostated water bath (95 ± 2°C) for 30 minutes. The resulted blue 
colour is detected spectrophotometrically at 790 nm, 810 nm and 780 
nm respectively for ampicillin, amoxycillin and carbenicillin. Beer's law 
limit and apparent molar absrorptivity has been reported. The precision 
of the method is checked by applying 10 replicate determination of 0.5 
mg of ampicillin, and 1.0 mg of amoxycillin and carbenicillin. Mean 
percent recovery and relative standard deviation at these concentration 
levels have been reported. The method was compared successfully with 
the reference method. Statistical treatment of the results has been 
reported. Maximum tolerance limit of interfering substances has been 
checked. 
Fourth chapter describes two separate methods for the analysis 
of (i) cefotaxime sodium and (ii) chloramphenicol. The estimation of 
cefotaxime is based on its reaction with ammonium metavanadate in 
sulphuric acid medium, resulting the formation of a blue coloured 
complex (Xmax 760 mm). While chloramphenicol is determined prior to 
its reduction with HCI/Zn dust, followed by its reaction with sodium 
nitroprusside in presence of sodium hydroxide to produce green colour 
(?.max 640 mm). Validity of the recommended methods is tested by 
appliying ten replicate determination of standard drug solution of 1.0 
mg (for cefotaxime) and 0.5 mg (for chloramphenicol). At these 
concentration levels mean percent recovery and relative standard 
deviation were found to be 99.98% and 0.28% respectively (for 
cefotaxime), and 100.14% and 0.19% respectively (for 
chloramphenicol). As an additional demonstration of accuracy and 
precision, experiments were performed by applying standard addition 
technique. The method has been applied successfully to the 
determination of these antibiotics in pure form and in pharmaceutical 
formulations. The results of the recommended methods were compared 
successfully with the reference methods in terms of accur.jcy and 
precision. 
The last chapter describes a simple kinetic spectrophotometric 
methoci for determination of kanamycin monosulphate using 
acetylacetone-formaldehyde reagent in N,N'-dimethylformamide 
solvent system. The absorption vs time curve is recorded at X^ iax '^ lO 
nm. The slope of the tangent to the absorption-time curve is used to 
measure the initial rate of reaction (Ro). A plot of log Ro vs Log C 
(molar concentration of kanamycin) gives calibration. Slope of the 
calibration curve gives order of reaction with respect to kanamycin 
concentration. The rate constant, K", with respect to kanamycin 
concentration is found to be 5.71 x 10^ min"^ and order of reaction 
being one. Beer's law was followed in the concentration range 60 - 150 
fig niL ' with mean percent recovery 100.07% and relative standard 
deviation of 0.78%. The results were compared statistically with the 
reference method. 
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CHAPTER ONE 
GENERAL INTRODUCTION 
It IS customary to credit ancient philosophers and scholars with 
being the forerunners of medicinal scientist, though in the context of 
current knowledge their experiments, observations, and interpretations 
must be regarded as purely heuristic, based on superstition and 
misunderstanding of natural phenomena, and without much predictive 
value in therapy. Nevertheless, the accounts of those deeds of 
antiquity, the middle ages, and even the first 350 years of the ''modern 
age" make fascinating anecdotal reading. Among the earliest materials 
known, from medicinal point of view, were ch'ang shangxw China (2735 
B.C.), which was later, identified as the antimalarial plant Dichroa 
febrifuga (1), Ebers Papyrus (Egypt, 1500 B. C.) mentions the use of 
squill as a cardiac tonic (2). Ipeacac, from Brazilian Cephaelis species, 
was used as an antiamoebic medication. Cinchona bark was usee as a 
chemotherapeutic agent by South American Indians, later reported as 
Pulvus indicus in 1643 by Herman van der Heyden. (3). The 
antimalarial alkaloid, quinine, was isolated from this bark only 200 
years later. The autumn crocus (meadow saffron, Colchicum 
autumnale) was recommended for relief from pain of the joints by 
Alexander of Tralles in the sixth century A, D., and for acute gout by 
Baron Anton von Storck (1763), later alkaloid colchicine (4) was 
recognised as the active antigout principle. Poppy juice was mentioned 
as an analgesic by Theophrastus (third century B. C.) 
The earlier name, pharmaceutical chemistry, reflected the fact 
that some nineteenth century pharmacists were the first to extract and 
purify naturally occurring drugs. Some of the tasks of medicinal 
chemistry as we know them today were claimed by biological sciences. 
S. C. F, Hahnemann (1755-1843), the founder of homeopathy, believed 
that drug solutions should be diluted to the point of practically omitting 
their content of active components because high concentrations of 
drugs produce toxic reactions. Samuel Thomson (1769-1843) stated 
that "all diseases are the effect of one general cause and may be 
removed by one general remedy" (5). Louis Pasteur's (1822-1895) 
discovery of pathogenic parasites as the causes of infectious diseases 
prepared the way for the healing of such diseases with chemicals 
(chemotherapy). Pharmacologist Buchheim in 1876 wrote that "the 
mission of pharmacology was to establish the active substances within 
the [natural] drugs, to find the chemical properties responsible for their 
action and to prepare synthetic drugs that were more effective" (6), 
The nature of the hormones had been anticipated by Aristotle who 
claimed that humors were secreted at certain cites to act elsev\here in 
the body. It required the birth of chemistry and the liberation of organic 
chemistry from preconceived ideas of mysterious forces. 
Thomas de Quincey (7) describes the dilemma of a friend of his, 
who was suffering from a lingering and fatal malady. His friend saw 
the necessity of reducing the daily dose of opium that he took to 
alleviate his pains to a minimum. The words of De Quincey, in this 
context can be quoted as; "But to do this he must first obtain the 
means of measuring the quantities of opium; not the apparent 
quantities as determined by weighing, but the virtual quantities after 
allowing for the alloy of varying amounts of impurity". Ultimately his 
friend achieved a fairly constant potency by extracting the opium. 
The gradual change from the use of natural products in their 
entire state to either purified extracts from those products or to 
synthetic chemically-produced materials can be said to have been 
taking place from the time of Paracelsus (IG*^ ^ century) to Ehrlich (19'" 
century). This period had been described as the period leading froin 
'Quintessence to Chemical' and has been reviewed by H. J. Barber (8). 
The wave of antiprotozoal chemotherapy set in motion around 
1890 and the early synthetic antimalarials intermingled with the 
development of hypnotics, anti-inflammatory drugs, and adrenergic and 
cholinergic hormones and drugs. These were followed by the discovery 
of antibacterials and antibiotics, while the pharmacodynamics of 
analgetics, antihistaminics, vitamins and new hormones moved to the 
fore. Major breakthrough's were observed in post-World War-II in the 
form of antituberculous agents, the steroid hormones and 
contraceptives, antipsychotic, anxiolytic and antidepressant psycho-
pharmacological drugs development. The sulfanilamide and 
antihistaminic agents of 1940s provided the first practical test of the 
validity of the rules of bioisosterism in drug design. 
In 1906 the Congress of the United States passed the Pure Food 
and Drug Act, which established more stringent and more desirable 
criteria of purity of drugs and food additives, and the laws were 
enforced by frequent inspection of the manufacturing facilities and 
methods by the Food and Drug Administration (FDA). Under these 
provisions, therapeutic research, drug development and 
introduction, and pharmaceutical manufacture entered their "golden 
age" (1940-1960). 
The application of increasingly sophisticated methods of 
structural analysis by spectroscopy, isotopic labeling, automated 
quantitative analysis, and separation by chromatography and other 
partition procedures opened avenues of study of minute amounts of 
biochemicals. 
It is important to note that all drugs contain impurities. These are 
resulted from many sources including from raw materials and reagents, 
as reaction by-products, and through degradation during manufacture 
and storage. There is need to pay considerable attention to the 
impurities, as these can have safety and efficacy implications, by the 
manufacturer and regulator^/ agencies. Impurities can be classified into: 
(i) Organic impurities, (ii) Inorganic impurities, and (iii) Flesidual 
solvents. Organic impurities may arise from starting materials, 
intermediates and synthetic by-products, or from reagents or catalysts, 
or as a consequence of degradation. Inorganic impurities may result 
from reagents, ligands or catalysts, as heavy metals or inorganic salts, 
Residual solvents are inevitable in drug substances since without 
solvents, the synthetic chemistry, purification, and generation of the 
desired ci^stal morphology would be impossible. 
Methods for inorganic impurities control, and appropriate limits 
are generally set by pharmacopoeial precedents, while for residual 
solvents drafting of guideline Is at its early stage. 
A key component of the guideline, and a fundamental 
concept in drug analysis is qualification v^ViicU is defined as "the process 
of acquiring and evaluating data which establishes the biological safety 
of the individual impurity or a given impurity profile at the level(s) 
specified" (9). The normal process of qualification occurs during the 
pre-clinical studies carried out during drug development, including 
components of both genetic and general toxicology. The 
pharmaceutical analyst must give careful thought to the analytical 
technology, Especially in the development phases, it may be necessan/ 
to utilize methods with high selectivity, including sophisticated 
techniques. Methods for identification and determination of impurities in 
drugs, using different techniques have been reported (10). 
METHOD VALIDATION STRATEGY 
Method validation is an important component in determining the 
reliability and reproducibility of bio-analytical methods, and is a 
requirement of any regulatory submission. The method should be 
defensible with respect to regulatory requirements and reliable by 
incorporating statistical analysis to evaluate its performance. Validation 
of analytical methods has been the subject of discussion in recent years 
(9,11-13). 
It has been agreed that the key for evaluation of method 
reliability and overall performance are: (i) analyte stability; (ii) method 
selectivity; (iii) limit of quantification; (iv) accuracy and precision; 
(v) relationship between response and concentration; (vi) recovery and 
(vii) ruggedness. Before an analytical method is used for routine 
analysis it must be demonstrated first that the method fulfils certain 
performance criteria, when this has been documented, the method is 
said to be validated. The process of method development and related 
documentation has been illustrated as in Fig. 1.1 (11). In the field of 
drug analysis, it is very clear that the definitions of validation of 
analytical method covers the entire field of analytical chemistr/ from 
bioanalysis to substance and product analysis. A number of definitions 
for method validation have been given by several international 
organizations. Some of the organisations and their applicability has 
been listed in Table 1.1 (12). 
The overall validation strategy consists of four components which 
are prevalidation, validation proper, study proper and statistical 
analysis. The purpose of method validation is to establish that an 
accurate, precise and rugged method has been developed. Ideally, all 
DEVELOPMENT OF NEW ASSAY 
METHOD 
Major changes required 
PROTOCOL 
i [STUDY CODE: VAL:0<XX] 
V 
METHOD VALIDATION STUDY 
Minor clianges 
^ 
VALIDATION 
REPORT 
METHOD SHEET 
VERSION: XXXX 
METHOD 
MODIFICATION 
Fig, 1.1 : Method development and related documentation 
the bioanalytical methods should be evaluated against the parameters 
listed in Table 1.2(13). 
Calibration range and linearity 
The calibration range will be defined by the expected 
concentration in the samples, and will be usually in the linear range of 
the detector for that analyte, where the determined response is directly 
proportional to the concentration. The calibration range should neither 
be too wide nor too narrow (11). Least-square linear regression is 
normally used to define the calibration line mathematically. The range 
of an assay method can also be defined as the concentration intervals 
over which an analyte can be measured with acceptable precision and 
accuracy, where as linearity of a method is where the determined 
response is directly proportional to the analyte concentration. It has 
Applicability 
Worldwide 
Worldwide 
Europe 
Europe, Japan, USA 
Worldwide 
Remark 
— 
— 
— 
Only for pharmaceutica 
products. Why not Bioanalysis 
Lacks selectivity and specificity 
been generally accepted that the coefficient of correlation of the 
calibration line should exceed 0.99 (14). 
Table 1.1: Validation of analytical methods- international 
definitions 
Organization 
' lUPAC" 
I LAC 
WE LAC 
ICH 
i ISO 
I 
Abbreviations: 
lUPAC; International Union of Pure and Applied Chemistry. 
ILJAC : International Laboratory Accreditation Conference. 
WELAC; Western European Laboratory Accreditation Cooperation. 
ICH: International Conference on Harmonization. 
ISO: International Organization for Standardization. 
Bias 
It is the difference between the expectation of the test results 
and an accepted reference value. Bias is a systematic error 
(determinate error) contrast to the random error. There may be one or 
more systematic error components contributing to the bias. A larger 
systematic difference from the accepted reference value is reflected by 
a larger bias value. Calibration curves are accepted for each individual 
batch during validation when no single standard has a % bias greater 
than 20% (11). 
Precision and accuracy 
The precision of a method is defined (15) as the closeness of 
agreement between independent test results obtained under prescribed 
conditions. It is normally expressed in terms of the relative standard 
deviation (RSD) of the determined concentration of a series of replicate 
assays of spiked samples. 
Table 1.2 : Bioanalytical method parameters that ideally 
should be examined for every assay and every 
analyte and every matrix. 
Calibration curve; 
Precision: 
Number of standards, concentrations, 
replicates and line fit. 
Intra-assay (within-day, repeatability) 
Inter-assay (between-day, reproducibility) 
Intra-assay (within-day bias) 
Inter-assay (between-day bias) 
What to do if the measured concentraticr is 
outside of this range: extrapolate curvi^  or 
dilute sample 
Accuracy; 
Limit of detection 
Limit of quantification 
Working concentration range 
of the assay; 
Linearity 
Selectivitv (Specificity) 
Matrix effects 
Recovery 
Stability; In drug solutions 
In the biological matrix under storage and 
room temperatures 
Investigate stability in the matrix between 
sampling and storage 
Extracts pending analysis 
Cross validation with another analytical technique 
Note: This list assumes the availability of an authenticated reference standard with 
known purity and confirmed structure. 
The accuracy (15) of a method is defined as the closeness of 
agreement between the test results and the accepted reference value. 
It is determined by calculating the percent difference (bias %) between 
the measured mean concentration and the corresponding nominal 
concentration, 
Limit of detection 
It determines the lowest amount of analyte that can be detected, 
as it (the analyte) yields instrumental response greater than a blank, 
but cannot be quantified. 
Limit of quantification 
It IS defined as the lowest concentration of analyte that can be 
measured and quantified, with acceptable precision and accuracy, by 
the method. Hence it is the lowest concentration included in the 
standard curve and is used to interpolate unknown sample 
concentration. 
Selectivity and specificity 
A selective reaction or test is one that can occur with other 
substances but exhibits a degree of preference for the substance of 
interest (16). It is a quantitative procedure, e.g. chromatography, ion 
selective electrodes. 
A specific reaction or test is one that occurs only with the 
substance of interest. It is a qualitative procedure, e.g. immunoassays. 
Recovery 
The recovery is a measure of the efficiency of the method in 
detecting all the analyte of interest present in the original sample. 
Recovery should be as high as possible, but it is more important that it 
(recovery) is constant within the calibration range (11). 
Repeatability and reproducibility 
Repeatability is the precision obtained by independent test results 
with the same method on identical test materials in the same laboratory 
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by the same operator using the same equipment within short intervals 
of time. 
Reproducibility is the precision obtained with the same method 
on identical test material in different laboratories with different operator 
using different equipments. 
Stability 
The stability of the analyte must be investigated under various 
conditions: in the standard solutions used to prepare calibration 
curves, in biological matrix, at different temperatures, at different 
pH, etc. 
Cross validation 
It IS a direct comparison of the new method developed vvith an 
independent assay method already existed and accessible to the' 
investigator. 
Recent trends (17-20) in pharmaceutical analysis emphasises the 
use of statistical analysis and evaluation of the method against 
statistical parameters like, correlation coefficient, variance, errors and 
confidence limits, limit of detection and sensitivity, standard deviation, 
relative standard deviation, \' and ^F' tests, standard deviation on 
slope and intercept, linearit\', residuals in regression analysis etc. A 
brief discussion is given below: 
Linear least square: The best straight line through a series of 
experimental points is that line for which the sum of the squares of the 
deviations of the points from the line is minimum. Besides determining 
a straight line, uncertainties in the use of calibration graph for analysis 
of unknown samples can be specified by this method of least squares. 
A straight line equation can be given by the following relationship, 
y = bx + a (i) 
Where y = instrumental response (i.e. absorbance) 
b = slope 
a = intercept 
'b' and 'a' can be calculated from the following relation, 
Ix,y, Kl>,Iy,)/n] 
or b -
y (7, X, /n 
(ii-a) 
(li-b) 
and a y mx (iii) 
where x, = individual value of concentration 
y, = individual value of absorbance corresponding to x, 
X = mean value of concentration 
y = mean value of absorbance 
n = number of data points in the straight line 
Correlation coefficient (r): The correlation coefficient, r, is used as a 
measure of the correlation between two variables i.e. correlation 
between absorbance (y) and concentration (x). The more closer the 
observed value of most probable values, the more definite is the 
relationship between V and V. In drug analysis it must exceed 0.99. 
The most convenient form of calculating V can be given as, 
or 
V x,y. - nxy jv-a 
Xx,^ -nxM(Xy,^-ny 
f^Z^iV.-Z^^Zv. 
y 
nZx^-(Zx,f|nSyMSy,)^ (iv-b) 
Standard deviation (s): It may be defined as the distance from the 
mean to the inflection point of the normal distribution curve. It can be 
calculated as, 
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N-l ^ - r - T - - (V) 
where., N = number of replicates of a single concentration value. 
Relative standard deviation (RSD): Precision of a method can be 
determined on the basis of relative standard deviation. Lower is the 
RSD greater is the precision, It can be calculated as, 
RSD=?xlO !vi) 
X 
Student's 't' test: In this test comparison is made between two sets 
of replicate measurements made by two methods; one is test method 
and the other is an accepted method. It can be represented as, 
±t= - - '—- - ^ ' - ^ (vii) 
where, Sp = ^ ^^^^1^2 
where, x, = mean recovery in method one 
X, = mean recover/ in method two 
Sp = pooled standard deviation 
Ni and N2 = number of replicates in method 1 and 2 
respectively. 
The calculated 't' value is compared with the tabulated 't' value at 
the desired confidence level and degree of freedom. If the calculated 't' 
value exceeds the tabulated 't' value, then there is a significant 
difference between the results of the two methods (i.e. the mean 
recoveries by the two methods are significantly different). It is an 
accuracy indicating test. 
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The 'F' test: This test indicates whether there is a significaiit 
difference between the two methods (i.e. the new method and the 
accepted reference method), 
It can be represented as, 
r- s: 
^~ -, (v i i i ) 
s; 
where, Si and S2= standard deviation of method 1 and 2, and Si > S; 
The calculated value of T ' is compared with the tabulated 
standard value at the selected confidence level and degree of freedom. 
If Fcaicuiated > Ftabuiated then there is a significant difference between the 
two methods. It is a precision indicating test. 
Variance: This is the parameter which tells about the scattering ot 
experimental data points around the line of regression. Smaller the 
value of the variance smaller will be the scattering of data points. It can 
be represented as, 
where, y = absorbance recorded for each number of obsePv'ation 
in the calibration curve 
Ycai = absorbance calculated from regression equation for 
each number of observation in the calibration cun/e. 
Detection Limit (DL): It is the lowest amount of analyte that can be 
detected from the instrument, as it yields an instrumental response 
greater than a blank. It can be calculated from the following relation, 
^^  = f ° N~l t (") 
where, S: = variance 
b = slope 
tp = tabulated value of r for N-2 degree of freedom at 
desired confidence level. 
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Standard deviation on slope (Sb): It can be calculated as 
' y / x 
fe(x,-xF (xi) 
where, 
or 
where, 
S^,, ' ^[si - v'^ Vahance 
y, = Ycai 
y = absorbance for each number of observation 
X = mean amount of concentration calculated from the oslibratioii 
curve 
n = number of data points in calibration curve 
Confidence limit for the slope; It determines whether the slope of a 
line differs significantly from a particular or predicted value. It can be 
calculated as, 
b i t s , (xii) 
where, t = tabulated Y value at desired confidence level for n-2 degree of 
freedom. 
Standard deviation on intercept (Sa): In can be calculated from the 
followinq relation 
S, - S y/x (x, - x)^ i 
(xiii) 
Confidence limit for intercept: It can be given as , 
a ± t Sa 
Linearity, Sb rel (o/o): It can be calculated in terms of (%) as, 
S. S, rel (%) 100 
(xiv) 
(XV) 
ANALYSIS OF DRUGS 
Analytical chemistry is an important branch of chemistry which 
has its influence on clinical analysis, pharmaceutical research, quality 
control and environmental analysis. In the pharmaceutical industn/ the 
quality and quantity of the manufactured drugs, in whatever from, must 
be carefully controlled. Slight changes in composition or in the purity of 
drug itself can affect the therapeutic values. In pharmaceutical studies, 
it is necessary to establish the properties and therapeutic values of H 
drug before it is approved and made available to the public, 
Establishment of the permissible level of dosage of a drug requires 
determination of its composition, its toxicity and its metabolite at 
various stages, 
The analytical method chosen for analysis should provide the 
best solution to the problem. Methods of quantitative testing and 
quality control of food and pharmaceuticals are regulated by Food and 
Drug Administration (FDA) within its jurisdiction with Good Laboratory 
Practice(GLP) and Good Manufacturing Practice (GMP). 
Today, pharmaceutical analysis is one of the main objectives of 
analytical chemists. Analysis in both, bulk as well as dosage forms is 
important. In many cases the matrix may be extremely complex 
therefore, detection, determination and separation are usually required. 
Usually method should be comparable to, or an improvement over 
methods published from standard (B.P, U.S.P, LP. etc) pharmacopoeial 
laboratories. 
The methods for analyzing medicinal agents are divided into 
physical, chemical, physico-chemical and biological. 
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Physical properties like solubility, transparency and degree of 
turbidity, colour, density or specific gravity, melting, boiling, and 
freezing points are studied in physical methods of analysis. 
Chemical methods used for the analysis of drugs are based on 
chemical reactions. They include the determination of ash content, pH 
of the medium and characteristical indices of oils and fats. Quantitative 
and qualitative analysis of drugs are generally carried out with respect 
to the functional groups present. 
Phys'co-chemical methods are used to study the physical 
phenomenon that occurs as a result of chemical reaction. 
Biological methods of analysis characterizes the pharmaceuticfll 
effect of the drug. Biological tests are conducted on animals and less 
frequently on isolated organs or part of organs of animals. The effect of 
drug is expressed in A.U.(Activity Unit) and is determined by the 
comparison with the activity of a reference substance. These methods 
are highly sensitive but often time consuming. 
The physico-chemical methods includes photometric (photo 
colorimietry and spectrophotometry), electro-chemical, electro-analyticai 
and chromatographic methods. Recently various kinds of physico-
chemical methods like NMR, mass spectrometry, gas chromatography, 
I.R. spectroscopy, Raman spectroscopy. X-ray powder diffractometry, 
dielectric relaxation spectroscopy, circular dichroism and diode array 
detection (DA) are being used in the qualitative and quantitative 
analysis of drugs. 
Thin-layer chromatography (TLC) is simple, rapid and in-
expensive, and widely used for the separation and identification 
of impurities and breakdown products and for semi-quantitative 
work (2.1). 
High performance thin layer chromatography (HPTLC) is fast 
chromatographic technique and flexible enough to analyse different 
kinds of samples. Scanning is performed in reflectance or transmittance 
mode by absorbance or by fluorescence. High performance liquid 
chromatography (HPLC) (22-23) is the most suitable and most 
extensively used chromatographic technique. It can separate and 
measure the drug from its degraded product(s) and excipients. HPLC 
offers great flexibility in the choice of mobile phase and stationary 
phase. The performance of the HPLC column is measured interms of 
height equivalent of theoretical plate (HETP). HPLC is often coupled 
with mass spectrometry (24) or pulse amperometric detector (25). 
In capillary electro-chromatography (CEC), a liquid mobile phase 
is driven through a stationary phase in a pack capillary column by the 
electro-osmotic flow (EOF) generated by a large difference in potential 
across the column (26). CEC can be applied with considerable 
advantages in the analysis of pharmaceutical compounds. It has been 
used in separation of diastereoisomers, which were not been separated 
previously by chiral HPLC column. 
Other chromatographic techniques recently being used are, 
supercritical fluid chromatography (27), and over pressured layered 
chromatography (28). 
In Flow Injection analysis (FIA) (29) a quantity of dissolved 
sample, accurately measured, is injected or introduced into the carrier 
stream flowing through the system tubing, with or without additional 
changes like chemical reaction etc, occuring between the sample and 
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the carrier. As the analyte (or its reaction product) passes through the 
continuous detector, a transient signal is generated and recorded. The 
method is simple, speedy and inexpensive. This technique has been 
utilized successfully in determination of some compounds of 
pharmaceutical interest (30-31). 
Electrochemical methods are characterised by high sensitivity, 
selectivity and accuracy. Electrochemical methods have been 
extensively developed and each of the basic electrical parameters like, 
current (I), resistance (R), and voltage (V) has been utilized alc^ ne or m 
combination for analytical purposes. Amperometric or coilometnc 
detectors, which are also coupled with HPLC, measures the current 
associated with the oxidation or reduction of solute. Pharmaceuticals 
containing phenolic, amino, hetrocyclic nitrogen, ketonic or aldehyde 
group undergo oxidation at their characteristic potential. Since all 
compounds undergo oxidation at their characteristic electrode potential, 
this increases the selectivity of the technique. Important 
electrochemical techniques being used in drug analysis like 
amperometry, conductometry, potentiometry, anodic and cathodic 
stripping voltametry, differential pulse voltametry and polarographv 
have been reviewed (32). 
Ion-selective electrodes are electrochemical sensors that allow 
potentiometric measurements of the activity of particular species ir 
aqueous and mixed solvents, or partial pressures of dissolved gases in 
water (33). 
Capillary zone electrophoresis is a technique in which an electric 
field is applied across a capillary filled with an ionic solution, anions are 
found to migrate towards the anode, while cations are moved towards 
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the cathode (34). But separation and determination of neutral species 
IS not possible by CZE, Hence miceliar eiectrokinetic chromatography 
(MEKC), an extended form of CZE, is employed for the separation 
of neutral species via the inclusion of micelles into the carrier 
electrolyte (35). 
Photocolorimetric methods of analysis are based on measuring 
the absorbance of non-monochromatic light of coloured compounds in 
the visible part of the spectrum. If the analytes are colourless, they are 
converted into coloured comipounds by reaction with suitable reagents, 
In the visible or the coiorimetric method, the intensity of the colour of" 
the analyte solution is compared to that of standard solution if the 
concentration of substance in known. Several methods have been 
reported for spectrophotometeric determination of drugs (36-37), 
Conventional ultra-violet (UV) spectrophotometric methods are 
simple, quick, economical and usually do not require an elaborate 
preparatory step prior to assay. However, UV method is not adequate 
when two or more drugs with similar UV spectra are present in the 
sample, or excipients or decomposition product(s) exhibits UV 
interferences (38). 
In recent years, pharmaceutical analysis has been characterized 
by the use of spectrophotometeric methods such are flame photometry, 
differential spectrophotometry and derivative spectrophotometry. 
Derivative spectrophotometry presents greater selectivity than 
does normal spectrophotometry and so offers a convenient solution to 
the problem of resolving spectral overlap in the analysis of 
multicomponent system (39). Peak-to-peak and base-l,ne 
measurements (generally referred to as graphical measurements), and 
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zero-crossing measurements are the most common techniques used to 
prepare analytical curves. Potential of the derivative spectrophotometn/ 
in clinical chemistry and pharmaceutical formulations have been 
discussed (40). 
Difference spectrophotometry is an important and useful 
technique used in the determination of medicinal substances by 
eliminat:mg specific interferences from degradation products, cci-
formulated drugs, and non-specific irrelevant absorption from the 
formulation matrix. The technique (41) involves reproducible 
alternations of the spectral properties of the absorbance difference 
between two solutions, provided that the absorbance of the other 
absorbing substance is not affected by the reagent(s) used to alter the 
spectral properties. 
Other techniques recently being employed in drug analysis are 
capillar/ electromigration technique (42), capillar/ electrophoresis (43), 
and resin bead detection method (44-45). 
Modern approach to biopharmaceutical analysis rely mainly on 
chromatographic and (or) imimunochemical methods, which are often 
time consuming. Immediate availability of a result is mandatory in 
many cases. Laboratory automation, through modern instrumental 
techniques and computers, and low cost microprocessors, is essential 
for shorting the analysis time in order to achieve high quality routine 
analysis. For this, kinetic automation methods are good choices for 
drug analysis as they permits sensitive and selective determination of 
many drugs within a fev^ seconds with no sample pre-treatment in 
many cases. Moreover, the instrumentations required are generally vet^ 
simple. 
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The principles and applications of kinetic methods have been 
reviewed(46), and appeared in books (47). Essentially, kinetic methods 
rely on measurement of changes in concentration (detected via signal 
changes) of reactants (which may be the analyte itself) with time after 
the sample and reagent(s) have been mixed. The use of kinetic 
methods in micellar media is one recent approach in kinetic studies. 
New kinetic chemometric (kinetometric) approach such as Kalman filter 
has been developed and applied to the simultaneous determination of 
various compounds of pharmaceutical interest. 
The Biological methods can be broadly categorised as: 
(i) classical microbiological methods (48) and their modifications, and 
(ii) physico-chemical techniques (49). 
In microbiological methods a living organism or tissue is assumed 
to act as reagent responding to the substance being investigated. This 
can be further classified as (a) diffusion methods, and (b) dilution 
techniques. 
In diffusion methods, inhibitor spreads uniformly into a solici 
medium from its point of application. As the inhibitor spreads its 
concentration decreases and where its concentration reaches to the 
minimum, the organism will grow. The inhibition zone diameter is 
usually (If not always) proportional to the logarithm of the inhibitor 
concentration, and is affected by various experimental factors. 
In respirometric methods, formation of carbon dioxide is inhibited 
by the drug under investigation either by direct of indirect action. 
Radioactive carbon dioxide, and Warburg or indicator methods can be 
used in drug estimation with the precaution that indicator should not 
interfere by complexing with the drug. 
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Turbidimetric method measures the inhibition of growth of the 
organism photometrically. Growth of the organism and the drug 
concentration are inversely related. 
In dilution methods, several dilutions of the drug are incubated 
with an inoculum of test organisms, and the lowest concentration of 
drug producing complete inhibition of growth of organism is tal^ en as 
the inhibitory concentration. 
Biological methods are usually inexpensive and simple, 
knowledge of the structure of the drug is not necessary, and do not 
need elaborate apparatus. But these methods are slow, have poc^ r 
reproducibility and precision, and can not be used qualitatively. 
The availability of sub-standard medicines to the general public 
poses many problems, both clinically and economically. Some 
literature (50) reveals that sub-standard pharmaceutical preparations 
are readily available, This may be due to poor manufacturino 
procedures, poor storage conditions or deliberate counterfeiting of 
branded or generic products. 
The analysis of drug entails, the following: (i) The quantitative 
and relative bioactivity assay of pure and impure drugs in different 
matrices; (ii) Elucidation of the mechanism of action of drugs at the 
molecular level; (iii) Clinical evaluation, including assessment of site of 
action (in vivo) and side effects. 
Quantitative drug measurements require to be of high reproduci-
bility, precision and accuracy, and should be efficient. In clinical 
laboratories (51) metabolic studies of drugs require detection at very 
low levels (upto ^ig-ng range), in body fluids and tissues. Same is the 
requirement in pharmaceutical industry also but since dosage forms are 
of high purity and precisely known composition the limit of detection 
are not so demanding as in clinical laboratories. 
As part of ongoing study, looking at the quality of 
pharmaceuticals it is necessary to assay samples of the drugs m 
formulations. Analysis of drugs are needed to characterise the true 
nature and degree of homogeneity of new materials, to provide the 
ultimate assurance on a batch by batch basis of newly manufactured 
material, and to provide an assurance of bioavailability. It is also 
needed to guard against error, deterioration, falsification, and to 
recongnise undesirable levels of impurities thus leading to an 
improvement in the quality of drugs in general. In examining the 
quality of the active ingredient present, it is of advantage to be able to 
detect starting materials and major decomposition products if these are 
present. This may allow to know the cause of any lack in quality 
determination. The method employed should allow rapid determination 
of the drug from the dosage forms with little sample pretreatment. In 
addition, the method should be validated following the current 
guidelines (11, 52-53). 
CLASSIFICATION OF DRUGS 
All the drugs according to their nature can be divided into organic 
and inorganic. They can be prepared synthetically (from chemicals) or 
from natural sources. All the drugs used in medicine can be broadly 
divided into two ways: 
1. Pharmacological classification 
In this class the drugs are divided according to their action on 
the organism/organ (viz. heart, brain, lymphatic system, respiratory 
system, endocrine system, CNS etc.). Hence these drugs can be divided 
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accordingly as narcotics, soporifices, analgesics, diuretics, and local 
anesthetics. 
2. Chemical classification 
here drugs are classified according to their chemical structure 
and properties, The pharmacological action is not taken into 
consideration. 
Few important classes of compounds, which are most widely and 
commonly used as drugs have been discussed below, 
Alkaloids 
Mostly alkaloids are of plant origin and rarely of animal origin. These 
are organic substances with basic character, due to the presence of 
nitrogen Mostly these are tertiary amines, except a few which ate 
seconda -^y amines or derivatives of tetrasubstituted ammonium bases. 
These have been successfully used as drugs in the treatment (f 
cardiovascular, nervous,, alimentary tract and other diseases (54!. 
This class can be grouped as, 
(i) Pyridine and piperidine derivatives (labelines, and its 
companions) 
(li) Tropane derivatives (atropine, hyoscyamines, cocaine etc ) 
(iii) Isoquinoline derivatives (opium) 
(iv) Indole derivatives (physostigmine, reserpine) 
(v) Imidazol derivatives (pilocarbine, omeperazole) 
(vi) Purine derivatives (caffeine, theobromine, theophylline etc.) 
(vii) Quinoline derivatives (quinoline, guidine etc). 
Antibiotics 
These are compounds that have inhibitory activity against 
microorganisms, eukaryotic cells, and viruses, and are produced by 
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secondary metabolism of living organisms and possess a variety of 
widely different chemical structures. In other words these are chemicals 
produced by microorganisms that inhibit the growth of other 
microorganisms. 
Antibiotics are generally grouped according to their backbone of 
structural units (55). Some antibiotics are the products of similar 
mechanism in different organisms and that these structurally similar 
products may exert their activities in a similar manner. 
The |3-lactam antibiotics (penicillins, cephalosporines, 
cephamycins etc.) are derived from amino acids. The oligo peptides 
containing pirol skeleton are represented by netropsin and kikumycins. 
The peptide and polypeptide antibiotics are representee by 
actinomycins with phenoxazine derivative unit. The molecules o' 
depsipeptides are built from hydroxy and amino acids with amide and 
ester linkages constructing linear or cyclic structures (e.g. validomycin, 
echiomycins etc). Aminoglycosides contains closely related amino 
sugar moieties (e.g. streptomycins, kanamycins etc). Nucleoside 
antibiotics includes compounds structurally related to purines (e.g. 
pyrrolopyrimidine) and pyrimidine (e.g. polioxins). Tetracyclines 
contains condensed aromatic system and has naphthacene skeleton. 
Polyenes and polyynes are linearly conjugated polyene and polyyne 
which can be best represented by mycomycin and isomycomycin, 
Macrolide antibiotics are built from a 12-,14-,16-, or larger macrocyclic 
lactone unit with one or two c = c to which deoxy or deoxyamino 
sugars are attached. Nitrogen containing heterocyclic antibiotics 
includes pyrrolnitrin with pyrrole skeleton, mitomycin with p-
benzoquinone skeleton, and anthramycine with substituted 
benzodiazepine skeleton. Griseofulvin is an example of oxygen 
containig heterocyclic antibiotics. Chloramphericol is one of the 
unclassified antibiotics accompanied by clotrimazole, erythromycin, 
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nalidixic acid, norfloxacin etc. Anthrone glycoside antibiotics are 
characterised by aglycone moities which can be examplified by 
mithramycin and mithracine. 
Various methods have been reported for determination of some 
of these antibiotics (56-58), 
Analgesics 
Those drugs which cause insensibility to pain without any laps of 
consciousness are called analgesics. There are various drugs which 
possess analgesic properties in addition to their specific 
pharmacological activities (59).This class of drugs can be grouped as 
sedatives (e.g. barbutrates), muscle relaxants, tranquilizers (e.g. 
meprobamate), compounds related to morphine (e.g. morphine, 
hydromorphine and codeine phosphate/sulphate etc.), synthetic 
analgesics (e.g. pentazocaine, methotrimeprazine, methadone 
hydrochloride, nefopam etc), antipyretic analgesics (e.g salicylic acid 
derivatives, arylacetic acid derivatives, aniline and p-aminoohenol 
derivatives, pyrazolone and pyrazolidine dione derivatives). Some of 
these drugs have been quantitatively analysed in pharmaceutical 
preparations and drug formulations by using various analytical 
techniques (60-66). 
Central nervous system depressants and stimulants 
Central nervous system is a compiex network of sub-units called 
neurons which acts as conducting pathways between the peripheral 
receptors and the effectors, enabling one to respond to ones 
environment. 
Those drugs which acts as depressing (relaxing) agent for the 
CNS are called CNS depressants (67). This class includes general 
anesthetics, hypnotic sedatives, muscle relaxants, tranquilizing agents 
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and anticonvulssants. General anesthetics and hypnotic sedatives 
produce generalized or non-selective depression on CNS function. 
Those drugs which elevates the activities of various parts of CNS 
are CNS stinnulants (68), 
Respiratory stimulants and Analeptics 
Respiratory stimulants are used to help to recover from the 
respiratory disorders. Carbonic acid is most effective drug of this class. 
Analeptics are drugs used to lessen the nacrosis brought about by 
excess of depressant drugs, often stimulates a variety of nerve centres. 
There are many drugs (e.g. cocaine, atropine, amphetamines, 
ephidrine etc.) of varying pharmacological classes, which in addition to 
their desired effect, elicit a pronounced stimulatory effect on central 
nervous system. 
Cardio-vascular agents 
Drugs used for their action on heart or on other parts of the 
vascular system to maintain the total out put of the blood to the 
optimum requirement for the distribution to certain parts of the 
circulatory system are called cardio-vascular agents. These drugs are 
also used to regulate the function of cardiac and smooth muscles. This 
class includes cardiotonic drugs, vasodialators, hypotensive drugs, 
antihypercholesterolemic drugs and sclerosing agents (69). Certain 
drug have a direct action on cardiovascular system, and in addition, 
they affect certain constituents of blood. The later includes 
anticoagulant drugs, the hypoglycemic agents, the thyroid hormones 
and the antithyroid drugs. Some of the antianginal drugs, with special 
reference to calcium channel blockers, have been quantitatively 
analysed in pharmaceutical preparations and drug formulations (70). 
There is a group of unclassified drugs, some of which have been 
estimated in pure form and pharmaceutical preparations (71-73). 
28 
Antibiotics are an important class of pharmaceutical compounds. 
Because of their wide application and extensive use as therapeutic 
agents, these drugs den-iand elaborate discussion. Hence, some of the 
important antibiotics have been discussed below. 
PENICILLINS 
An antibacterial substance from Penlcillia was discovered by Sir 
Alexander Fleming in 1929 (74) and subsequently recognised in 1940 
by Florey, Chain, and Abraham. Potential utility of this substance for 
controlling infections, by inhibiting the growth of certain bacteria, has 
been recounted many times (75). Pencillin was first obtained as a 
product of the fungus Penicillium notatum. The discovery of penicillins,, 
the first antibiotic to find practical use in man has opened the era of 
antibiotics. 
Table 1.3 summarizes the essential features of the naturally 
occurring penicillins. All penicillins have a 4-membered p-lactam rincj 
(Table 1.3) which is fused through the nitrogen and the adjacent: 
tetrahedral carbon atoms to a heterocyclic five membered thiazolidint' 
ring. Carbon atom attached to the lactam nitrogen bears a carboxyi 
group, and an acylated amino group is attached to the carbon atoni 
opposite to the nitrogen of the p-lactam ring. Hence all the peniciilin5> 
have the general molecular formula C9H11N2O4SR, differing only in the 
nature of R. Penicillins are used in treating infectious diseases caused 
by gram positive as well as gram negative bacteria in man and animals. 
The first successful synthesis of penicillin analogs (76) was 
carried out by Sheehan et al. (1957, 1959) [Fig. 1.2]. Some of the 
clinically important penicillins are listed in Table 1.4 (76). 
Because of their extensive use in pharmaceuticals it is essential 
to analyze the quality and quantity of these antibiotics. 
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Ampicillin (a-aminobenzylpenicillin), amoxycillin (cx-amino-p-
hydroxybenzylpenicillin), and carbeniciliin (a-carboxybenzylpenicillin) 
Table 1.3: Essential features of naturally occurring penicillins 
H 
RCONH—--T" -
i i ' ^ C H o 
0 H CO2H o"-
; ; ^ 
I 1 
A N 
Penicillin 4-membered p-lactam 'ing 
Chemical name 
Pent-2-enylpenicillin 
Benzylpenicillin 
p-Hydroxybenzylpenicillin 
n-Heptylpenicillin 
n-Amylpenicillin 
^ Phenoxymethylpenicillin 
Other names 
Peniciilin-I or F 
Penicillin - I I or G 
Penicillin - I I I or X 
Penicillin -IV or K 
Dihydro - F- penicillin 
Penicillin - V 
R 
-CH2CH = CHCH2CH3 
-CH2C6H5 
-CH2C6H40H(1,4) 
-(CH2)5CH3 
-(CH2)4CH3 
-CH2OC6H5 
are broad spectrum semisynthetic penicillins widely used to treat 
commonly occurring diseases. 
Several procedures have been reported for the analysis of penicillins 
These antibiotics have been analyzed by alkaline degradation (77) and 
TLC (78), Other methods including titrimetry, spectrophotometry, 
flourimetry, HPLC and polarography have been reviewed (79). 
Colorimetric methods used for quantification of penicillins 
includes their reaction with chromogenic reagents such as copper 
sulphate (80), and mercuric chloride and imidazole (81). In a 
spectrophotometric method penicillins were boiled with ammonium 
meta-vanadate to produce blue colour (82). Formaldehyde and 
chromotropic 
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Fig. 1.2: Total synthesis of penicillin analogs (Sheehan) 
acid were the basis of colour formation for the method adopted by 
Marchi (83). Flow injection analysis has been reported for 
determination of amoxycillin and ampiciliin (84). 
Penicillins in combination provides a broader spectrum of 
antibacterial activity and may be advantageously prescribed in cases of 
5 1 
(Vlactamase producing strains. Determination of ampicillin in presence 
of cloxacillin has been reported (85). The British Pharmocopoeia (86) 
recon-imends a difference spectrophotometric method for the assay of 
ampicillin, cloxacillin and amoxycillin at Xmax 325, 348 and 325nm 
respectively, ampicillin and amoxycillin being absorbed at the 
same Anax. 
The most commonly quoted chemical assays of penicillins are 
based on estimation of unconsumed iodine after its incubation with 
hydrolyzed penicillin (87), and reaction of penicillins with 
N-bromosuccinimide followed by titration of the librated iodine from 
potassium iodide by the residual NBS (88). Adam et al (89) have 
proposed an enzymatic penicillin assay based on a pH-state instrument 
incorporating coulometric generation of titrant. 
The spectrophotometric methods for determination of ampicillin 
and amoxycillin are mainly based on the use of equilibrium methods. 
These methods usually involves hydrolysis of the p-lactam ring prior to 
their assay (90). 
In chromatographic methods, for detection and determination of 
ampicillin, amoxycillin, and other penicillins, reverse phase separation 
column at pH ~ 7 with detection at 240 nm has been reported (91). 
Here amoxycillin was used as the internal standard for ampicillin, and 
phenoxymethylpenicillin was used as the internal standard for 
amoxycillin. Other chromatographic methods includes determination 
and monitoring of aziocillin during bulk analysis (92). Benzylpenicillin 
has been determined in pharmaceuticals by capillary zone 
electrophoresis (93). A collaborative study for determination of 
penicillin V in tablets has been reported (94). The effect of pH and 
buffer concentration on the response of an enzyme membrane coated 
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Table - 1.4: Some of the clinically important penicillins 
RCONH-
H H CH 3 
CHo 
O , ^ " " - / \ 
Generic Name 
Narrow spectrum 
Benzylpenicillin 
Phenoxymethylpenicillin 
p-Lactamase resistant 
MethiciHin 
Oxacilim 
Cloxacillin 
Dicloxacillin 
X 
H 
H 
CI 
Y 
H 
CI 
CI 
H CO2H 
/ / \^  
// \^  
CH^  
OCH^ 
OCH-. 
OCH, 
II I 
- o ' 
CH, 
Nafcillin 
Broad spectrum 
Ampicillm 
Amoxycillin 
Epicillin 
Broad spectrum-Narrow use 
Carbenicillin (and side chain esters) 
Ticarciilin 
Cu°^ "^  
w // 
D 
CH-
NH. 
HO- w // 
D 
-CH — 
NH 2 
/ / / ^ — C H -
NH. 
w // -CH-
CO2H 
- C H — 
^ S ^ CO2H 
wire electrode during analysis of penicillin have been studied (95). 
First derivative spectroscopy was the basis of one method 
reported for quantification of amoxycillin and clavulanic acid in 
pharmaceutical preparations (96). Morelli has developed second 
derivative spectroscopy for the determination of ampicillin and 
dicloxacillin (97), and ampicillin and cloxacillin (98). 
Several methods have been reported for quantitative estimation 
of amoxycillin alone or in combination with other penicillins (99-100). 
Degraded products of amoxycillin have been identified by micellar 
electrokinetic chromatography (99). Devani ef a/has advocated the use 
of acetylacetone-formaldehyde for the quantitative assay of amoxycilln 
(100). Acenaphthenequinone has been used as the chromophoric 
reagent in the quantitative assay of ampicillin and 6-aminopenicillinic 
acid (102). 
Table 1.5: Essentials of naturally occurring cephalosporins 
H 
0 -
HO-,CCHCH^CH^CH.^CONH r— 
NH2 o'-' 
Cephaloporin 
Name 
Cephalosporin C 
Deacetylcephalosporin C 
Deacetoxycephalosporin C 
— 
H 
1 CO2A , 0^/ 
CO2H 
4 - membered p-lactam ring 
A 
OCOH3 
OH 
H 
OCONH2 
SCH3 
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Penicillins have been estimated by conductimetric titrimetry 
(103). Spectroflourimetric determination of amoxycillin, through the 
formation of its coumarin derivative has been reported (104). Other 
methods used in the quantification of penicillins includes their reaction 
with Ellman's reagent (105i), flow injection analysis (106), pola-ography 
(107) and reversed phase HPLC (108). 
CEPHALOSPORINS 
Cephalosporins are an important group of p-lactam antibiotics. 
Discovery and development of these antibiotics began in 1948 with the 
finding by Brotzu that a Cephalosporium species produced antibiotic 
material that was active against certain gram negative as well as gram 
positive bacteria (109). This fungus produced at least six antibiotic 
substances five of which were steroidal (cephalosporins PrPs). After 
extraction of cephalosporin P a major hydrophilic component was found 
in the antibiotic broth, named as cephalosporin N, which was found to 
be susceptible to degradation by penicillinase. Later it was renamed as 
penicillin N, Abraham and Newton discovered a second hydrophilic 
antibiotic that had sur^/ived the degradation (110) and it was named as 
cephalosporin C. Naturally occurring cephalosporins with their basic 
structural features have been reported in Table 1.5 (76). 
Woodward and co-v^orkers (111) achieved an exquisite synthesis 
of cephalosporin C and clinically useful analog cephalothin. Various 
synthetic pathways have been illustrated in Fig. 1.3. 
Essentially cephalosporins have the same structural features as 
that of pencillins except that a six membered dihydrothiazin ring is 
fused with the p-lactam ring instead of a five membered thiazolidine 
ring, as shown in Table 1.5. 
The p-lactam ring in cephalosporin C resists opening by both acid 
and penicillinase, hence it is much more stable than penicillins. 
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CHoCHoCCIo 
Fig. 1.3: Synthesis of cephalothin, analog of cephalosporin C 
(Woodward) 
These antibiotics are broad-spectrum with low toxicity, and cross 
allergenicity, and shows good stability towards acids and p-lac':amase. 
These have wide range of activity and are used to treat infections 
where pencillins are proved to be ineffective. 
Table 1.6: Some of the clinically important cephalosporins 
Generic Name 
Injectable 
Cephalothin 
Cefazolin 
Cephacetriie 
Cephaloridine 
Oral 
Cephalexin 
Cephradine 
H H 
RCONH 
O 
^ N 
r^  
•CH2A 
CO2H 
X H 2 -
N N 
N : v , / N — C H 2 -
N =z CCH. 
\ c 
X H 2 -
// V C H 2 -
NH. 
D 
CHo— 
NH 
— OCOCH, 
N N 
CH-
OCOCH. 
+ / / \ \ 
- N ^^ 
V 
— H 
— H 
Some of the clinically important cephalosporins have been listed 
in Table 1.6 (75). Some of the cephalosporins have been subjected to 
extensive pre-marketing clinical evaluation, [Table 1.7] (76), so that 
their range of activity against pathogenic microorganisms is extended 
[Table 1.6]. Traditionally cephalosporins are divided into first-,second-, 
third-, and fourth generation of cephalosporins. 
Table 1.7: Some of the cephalosporir^s with clinical evaluation 
Generic Name 
Injectable 
Cephazaflur 
H H 
RCONH- r 
-K 
O' 
CO2H 
R 
CF3SCH2— 
N - N 
CHjS'^ N 
Cefuroxime 
Cefotaxime 
Oral 
Cefatrizine 
Cefachlore 
Cefadroxi 
7 V 
o' 
N0CH3 
NOCH. 
N — r - C -/ VT 
H^N-" ^S 
HO ^ ^ -CH-
NH^ 
/ / \ \ 
-CH-
NH-
HO r ^'^—CH -
NH^ 
-CH2OCONH2 
•CH2OCOCH3 
•CH' 
N 
y ^^  
,.N 
N 
H 
•CI 
-CH, 
Because of their wide application in modern medicine as broad 
spectrum antibiotics, it is necessary to regulate their purity and 
estimiate them qualitatively as well as quantitatively. 
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Several methods like, thermogravlmetry, spectrophotometry, 
spectroscopy, chromatography, etc. for determination of cephalosporins 
have been reviewed (79). These antibiotics have been det(!rmined 
iodometrically after hydrolysis of the p-lactam ring (86). In titrimetric 
estimation of cephalosporins, Alicino has used N-bromosuccinimide 
(112), while Grime and Tan have used potassium iodate (113) as titrant 
in redox titration of these antibiotics in strong acidic medium, These 
antibiotics have been determined spectrophotometrically using 
hydroxylamine-nickel reagent (114). An air-segmented continuous f\ov\i 
spectrophotometric method has been utilized for the determination o^  
cephalosporins (115). Cephalosprins have also been determined by 
fluorescene quenching method (116). To study the kinetics of 
degradation of cephalosporins, Yamana et al {117) have used iodimetric 
titration and U.V. spectrophotometry. Yamana and Tsuji (118) have-
used HPLC, iodimetry and hydroxamic acid assays of cephalosporins 
The classical methods used in determination of cephalosporins have 
been reviewed (119). First report of d.c. polarographic determination o\ 
cephalosporins seems to be that of Jones et al {12{)). Fogg (121) has 
reported a differential pulse polarographic determination of 
cephalosporins and their degraded products. A novel TLC system (122) 
has been proposed for the separation and identification of 
cephalosporins. Identification of various cephalosporins by TLC on 
silanized silica gel layers containing a fluorescence indicator has been 
reported (123). Several spectroscopic methods used for identification of 
these antibiotics have been reported (124). 
Flow-injection analysis for automated determination of j3-lactam 
antibiotics has been reported (125). In this method immobilized 
enzyme reactors with thermistor or ultraviolet spectrophotometric 
detector was used. 
First generation cephalosporins (cefadroxil monohydrate, 
cepliazolin sodium, cephalexin monohydrate, cefapirin sodium and 
cepharadine) have been determined colorimetrically (126).In this 
method antibiotics reduces Fe(III) to Fe(II), which then reacts with 
1,10-phenanthroline to form deep red ferroin indicator, [Fe(II)-(0-
Phen)"^]'^  complex. 
Spectrophotometric determination of cephalosporins involves 
based hydrolysis followed by formation of ethylene blue (127). Reaction 
of these antibiotics with chlorobenzotriazole and sodium hypochlorite 
results in the formation of chromogen detected spectrophotometrically 
(128). Some of the cephalosporins were spectrophotometrically 
estimated by their reaction with Ellman's reagent an^ the coloured 
product was measured as 410 nm^^ii'^). 
Cefuroxime, a semi-synthetic cephalosporine, was spectrofluon-
metrically analyzed by Murillo (130). In this method the drug was 
hydrolysed and the fluorescence intensity was measured at 436 nm 
with excitation at 380 nm. Cephalosporins such as ceftazidime, 
ceftizoxime and ceftriaxone have been estimated by differential pulse 
polarography (131). Binary mixtures of cephalothin and cefoxitin were 
analyzed by using first-derivative spectrophotometry (132). Formation 
of yellowish brown complex between Pd(II) chloride and cephalosporins 
in presence of lauryl sulphate has been reported by Walily et al. (133), 
Sastn/ et al. have reported a simple spectrophotometric method for 
quantitative estimation of these antibiotics (134). Batch and flow 
injection procedures have been applied recently for the assay (Df some 
of the cephalosporins (135). 
CHLORAMPHENICOL 
Chloramphenicol is an important anti-biotic. It is produced by 
Streptomyces venezuelae, an organism first isolated in 1947 from a soil 
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sample collected in Venezuela. Filtrates of liquid cultures of the 
organisms were found to posses marked effectiveness against several 
gram negative bacteria and also exhibited antirickettsial activity A 
crystalline antibiotic substance was then isolated and named 
'Chloromycetin' as it contained chlorine and was obtained f'om an 
actinomycete, When the structural formula [Fig. 1.4] (76) of the 
crystalline material was determined, the antibiotic was prepared 
synthetically. But by 1950, it became evident that the drug could cause 
serious and fatal blood dyscrasis, if taken for a longer period or due 
to overdose. Chloramphenicol exhibits a fairly wide 
NO-
LO 
HO—C—H 
I 
H —C—NH —CO —CHCI2 
CH2OH 
Fig. 1.4: Structure of Chloramphenicol 
spectrum of antimicrobial activity. It is primarily bacteriostatic, although 
it may be bactericidal to certain species under some conditions. It is a 
white or yellowish-white, fine crystalline powder with melting point 
149°C to 153°C. Slightly soluble in water, freely soluble in alcohol. 
Chloramphenicol and its esters are broad spectrum antibiotics of 
wide therapeutic application. The assay of these drugs have been, and 
is still the subject of much investigation. 
Titrimetric method based on acid hydrolysis of the drug then one 
step oxidation of the base product with K2Cr207 has been reported for 
the assay of chlorampenlcol in capsules (136). B.P. method describes 
quantification in UV range by measuring the maximum absorbance at 
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278nm (137). Mercurometric determination of chloramphenicol is the 
basis of one method (138). Oxidation of chloramphenicol with H2O2 in 
alkaline medium gives yellow color readable at 410nm (139). Cenmetnc 
titrimetry has been employed by Koka for quantitative estimation of 
chloramphenicol (140). Quantitative estimation of chloramphenicol has 
been made by alkalimetn/ in dimethylformamide. In this method 
chloramphenicol is dissolved in DMF mixed with 2-nitroaniline indicator 
and titrated with O.IM NaOMe in CeHe-MeOH (4:1) (141). 
For kinetic study of chloramphenicol secondary alcoholic group in 
the drug was oxidized to keton by NBS (142). Al-Saidan (143) has 
proposed spectrophotometric full spectrum quantification (FSQ) and 
HPLC for the assay of chloramphenicol in formulations. Several methods 
for qualitative and quantitative determination of chloramphenicol 
including spectroscopy, spectrophotometry, chromatography, etc. have 
been reviewed (79). 
Micellar modified spectrophotometric determination of 
chloramphenicol is based on reduction of the drug with tin (II) followed 
by diazotisation and coupling with the Barton-Marshall reagent (144). 
Other methods used for quantitative assay of chloramphenicol includes 
atomic absorption spectroscopy (145), spectrophotometry (146) and 
spectroelectro-chemistry (147). 
AMINOGLYCOSIDE ANTIBIOTICS 
This group of antibiotics includes streptomycins, neomycins, 
paromomycins, gentamicins and kanamycins. They are all mixtures of 
closely related, water-soluble, basic carbohydrates that form cn/stalline 
salts. The streptomycins contains streptidine, which is a diguanidyl 
derivative of 1,3-diaminohexose (streptamine) and each of the other 
membe,s of this group contains a 2-deoxystreptamine or related unit. 
Structures of streptomycin and kanamycins have been shown in Fig. 
1.5 (76). All these antibiotics show antimicrobial activity. None of these 
are absorbed from the alimentary tract. 
The first antibiotic discovered in this group, streptomycin, was 
isolated from Streptomyces griseus (148). It is active against gram 
positive and gram negative bactena as well as mycobacteria and 
spirochetes. 
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Fig. 1.5: Structure of Streptomycine (A) and Kanamycin (B) 
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Kanamycin is an important antibiotic of this group. This antibiotic, 
produced by Streptomyces kanamyceticus, was discovered by Umezawa 
in 1957. Kanamycin is tetrabasic and very stable in the pH range 
2.0-11.0, It has a large antibiotic spectrum, similar to that of 
streptomycin. The structure of kanamycin A (Fig. 1.5) (76) was 
established independently by an American-Canadian group and a 
Japanese group, which was later confirmed by its synthesis (149). 
Kanamycin A is accompanied in the culture filtrate by kanamycin B and 
kanamycin C. 
Kanamycin A is white crystalline powder soluble in 8 parts of 
water, practically insoluble in acetone, alcohol and ether. 
The structure - activity relationships among the aminoglycoside, 
especially the role of hydroxyl and amino groups, have been studied 
(150). Relationships among the aminoglycoside antibiotics have been 
summarized in Table 1.8 (76). 
Aminoglycoside antibiotics are therapeutically important for the 
treatment of severe infections. Hence, they require potency and purity 
test for certification, as required by the Code of Federal Regulations. 
Several methods for quantification of aminoglycosides have been 
reported (79). U.S. Pharmacopoeia recommends microbiological 
method (151) for the assay of kanamycin. Formation of aldehyde from 
neomycin followed by its condensation with phloroglucinol in 
concentrated HCI is the basis of the method adopted by Morgan et ai. 
(152). Neomycin has been determined by forming a complex with 
Cu-tartarate (153). Amino acid estimation method has been employed 
for the determination of neomycin (154). Disodium pentacyanonitrosyl-
ferrate(II) was used by Cofino for the assay of aminoglycosides (155) 
Neomycin, gentamycin and kanamycin have been quantitatively 
determined by TLC (156). An extractive spectrophotometric method 
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(157) has been reported for the quantification of cifferent 
aminoglycosides. Ninhydrin has been used as the coloring reagent for 
the estimation of neomiycin and other aminoglycosides (158). 
Streptomycin has been determined spectrophotometrically (159). In 
this method the acid hydrolysed product of streptomycin was reacted 
with brucine and 
Table 1.8; Relationship among the Aminoglycoside Antibiotics 
N a m e 
1 
Gentamycin Ci i 
Gentamycin A 
Kanamycin A 
Kanamycin B 
Kanamycin C 
Neomycin B 
Neomycin C 
Paromomiycm I 
Streptomycins 
Hydroxy-
streptomycin 
Dihydro-
streptomycin 
Source 
Micromonospora 
purpurea 
M. purpurea 
Streptomyces 
kanamyceticus 
5. kanamyceticus 
5. kanamyceticus 
S. fradiae 
S. fradiae 
S. rimosus forma 
paromomomycinus, 
5. pulveraceus 
S. griseus, 
S. mashuensis 
S. griseacarneus, 
S. reticuli 
S. fiumidus, also 
produced by chemical 
reduction of 
streptomycin 
Chemical Features 
Base 
Deoxystreptamine 
Deoxystreptamine 
Deoxystreptamine 
Deoxystreptamine 
Deoxystreptamine 
Deoxystreptamine 
Deoxystreptamine 
Deoxystreptamine 
Streptidine 
Streptidine 
Streptidine 
Amino Sugar 
Garosamine 
2-Amino-2-deoxy-glucose 
3-N-methyl-
3-deoxygIuco9e 
3-Aminoglucose, 
6-aminoglucose 
3-Aminoglucose pluse 
unknown amino sugar 
3-Aminoglucose 
D-glucosamine 
2, 6-Diaminoglucose, 
neosamine B 
2, 6-Diaminogiucose, 
neosamine C 
D-Glucoseamine, 
neosamine B 
L-N-Methyl-glucosamine 
L-N-Methyl-glucosamine 
L-N-Methyl-glucosamint; 
sodium metaperiodate forming bruciquinone derivative. IR-reflectance 
spectroscopy has been employed by Blanco et al for quantitative 
estimation of miokamycin (160). Morovjan has recently used post-
column derivatization and fluorescence detection of aminoglycosides 
(161). Streptomycin sulphate has been estimated volumetrically (162). 
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Fluorescence reagent with pre column (163) or post column (164) 
derivatization with flourimetric or UV detection has been employed for 
the quantitative assay of aminoglycosides. An excellent review on 
methods adopted for estimation of aminoglycosides has been reported 
(165). 
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CHAPTER TWO 
B A S E CATALYSED HYDROLYSIS OF AMPICILLIN, 
AMOXYCILLIN A N D CARBENICILL IN BY ALIPHATIC 
A M I N E IN A SINGLE STAGE REACTION A N D THEIR 
DETERMINATION BY SPECTROPHOTOMETRIC AND 
VOLUMETRIC METHODS: MECHANISM OF DEGRADED 
PRODUCTS OF ANTIBIOTICS BY T L C , 1R, U V 
SPECTROSCOPY A N D MOLE STOICHIOMETRIC RATIOS 
OF REDUCING (ANTIBIOTIC) A N D OXIDIZING (IODATE) 
SUBSTANCES 
Ai 
INTRODUCTION 
Ampicillin (cx-aminobenzylpenicillin), Amoxycillin (c.-amino-p-
hydroxybenzylpenicillin), and Carbenicillin (a-carboxybenzylpeniciilin) 
are broad spectrum semisynthetic penicillins widely used in the 
treatment of commonly occurring diseases. Their structures have been 
reported in Table 2.1. 
Several methods have been reported for the quantitative 
estimation of these penicillins alongwith other penicillins. Liquid 
chromatography has been employed for determination of penicillins by 
post-column alkaline degradation (1). Ampicillin and amoxycillin have 
been determined by forming charge transfer complex with some 
Ti-acceptors (2). Condctimetric titration (3) has been used to estimate 
ampicillin and amoxycillin in dosage forms. The end point in tliis 
titration corresponds to one equivalent of acid in the titration curves of 
ampicillin and amoxycillin, which was attributed to the protonation of 
nitrogen located in the p-lactam ring. Ampicillin has been determined 
spectrophotometrically by alkaline degradation yielding ammonia which 
was determined by indophenol formation (4). Mercurimetry has been 
used for the quantification of benzylpenicillin (5). Piperazin-2,5-dione 
derivative was found to be a major degradation product of ampicillin in 
phosphate buffer or solutions containing imidazole or phenol. This on 
treatment with 0.5-2 M NaOH yields chromophore readable at 322 nm 
(6). A new spectrophotometric method for determination of ampicillin, 
amoxycillin and cyclacillin has been reported (7). Issopoulos has 
employed copper (II) acetate as the complexing agent for the 
determination of ampicillin, amoxycillin and other p-lactam antibiotics 
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(8). Ampicillin and amoxycillin have been quantified 
spectrophotometrically (9). In this method the penicillins were mixed 
with 2-nitrophenyl hydrazine hydrochloride, dicyclohexyl carbodi-imide 
and pyridine. The reaction mixture was heated and mixed with 
ethanolic potassium hydroxide solution resulting in the formation of a 
chromophore readable at 546 nm. Other spectrophotometric methods 
includes use of colouring reagents such as hydrochloric acid-
formaldehyde (10), eerie salts (11), paramolybdate ion (12), sodium 
cobaltinitrite (13), 3,5-dinitrobenzoic acid (14) and N-halosuccinimide 
(15), Derivative spectrophotometry has been reported ^or the 
estimation of amoxycillin in the presence of dicioxacillin (16). British 
Pharmiacopoeia recommends mercurimetric titration and UV-
spectrophotometry for the assay of amoxycillin in bulk and in 
pharmiaceutical dosage forms. Penicillins have been separated and 
quantified by TLC (17). Indirect spectroflourimetric determination of 
ampicillin and carbenicillin has been reported (18). In this method 
excitation and emission wavelengths were 470 nm and 548 nm, in the 
presence of Triton-100. \'i'^\c-\'>^T\^ V\o>-v^ , been detsrmined 
spectrophotometrically '•')) '^ n.d \\k-r\-r'\^^-<r\ c^'i t^  (>«"). PS '^^ '^^ +IMJ .sei->yH'^ 'V 
OA-n-^ tp''-''''• >\amoxycillin and other penicillins have been studieid. This 
method is based on application of pH-sensitive electrolyte-insulator 
semiconductor (EIS) sensor (21). 
The volumetric estimation of penicillins involves their oxidation 
prior to a base or acid hydrolysis. Oxidizing titrants like Hg (II) (22) or 
potassium lodate (23) have been widely used in such type of assays 
Different pathways of hydrolysis mechanism results with change in 
hydrolysis conditions like change in concentration of alkali or acid. Ir; 
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direct titration of antibiotics with iodate (23), strong acidic conditions 
are maintained. Here acid brings hydrolysis of the antibiotics besides 
making the iodate titration feasible. But such titrations have certain 
limitations which have been discussed later in discussion of this 
chapter. 
In this chapter penicillins (ampicillin, amoxycillin and carbenicillin) 
were hydrolysed in the presence of aqueous solution of diethylamine. 
The degraded hydrolysed products were acidified with dilute 
hydrochloric acid followed by titration with potassium iodate. The 
liberated free iodine gives deep red-violet colour in the non-aqueous 
layer, which can be determined spectrophotometrically. The mechanism 
of degraded products has been discussed in the light of various studies 
e.g, TLC, IR and stoichiometric molar ratio. The results obtained by 
recommended method were compared with the reference method (12) 
and found to be in good agreement. 
EXPERIMENTAL 
Apparatus 
A Spectronic 20D^ (Milton Roy, USA) and a splitbeam 
Spectronic 1001 (Baush and Lomb) spectrophotometer with 1-cm path 
length matched quartz cells. IR spectra of the isolated products were 
recorded on Shimadzu IR-408 (Japan) with KBr disc. Thermostated 
water bath (NSW-ISS, India) and pH meter (Elico, LI-IOT, India) were 
used. 
Reagents 
1.0 M each of diethylamine and hydrochloric acid, and 0.01 M 
potassium iodate were prepared in distilled water. 
All reagents used were of analytical grade. 
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Preparation of standard drug solution 
Standard solutions of penicillins, 1 mg ml'\ were made by 
dissolving pure and standard drugs (Sigma Chem. Co., USA) in distilled 
water and stored in a dark and enclosed container to avoid any direct 
exposure to the light. 
General procedure 
Procedure I: Simultaneous determination of penicillins by 
volumetric titration against standard potassium iodate solution 
followed by the spectrophotometric determination of coloured 
solution in non-aqueous layer 
Suitable amounts of ampicillin (0.3-1.9 mg) amoxycillin 
(0.3-1.9 mg), and carbenicillin (0.3-2.0 mg) were pipetted into 50 mL 
conical flasks followed by 5 mL of 1.0 M diethylamine (resulting an 
initial pH ~ 12.25). The flasks were placed in a thermostated water 
bath at 80 ± 2°C for 20-25 minutes. After heat treatment the flasks 
were taken out and cooled at room temperature, followed by addition 
of 1.2 mL of 1,0 M hydrochloric acid (resulting a final pH ~ 1.4) and 5 
mL of carbon tetrachloride. The whole contents were titrated wth 0.01 
M potassium iodate with vigorous shaking. The end point was detected 
as a change of colour in non-aqueous layer, from colourless to deep 
red-violet colour. For spectrophotometric determination the non-
aqueous layer was separated from the aqueous layer using a 50 mL 
separatory funnel. It was dried over anhydrous sodium sulphate and 
absorbance was recorded at Xmax 520 nm, against a blank containing all 
reagents except the drug. 
Procedure I I : Spectrophotometric determination of penicillins 
A suitable amount of ampicillin (0.3-2.1 mg), amoxycillin (0.3-2,2 
mg) and carbenicillin (0.3-2.4 mg) were taken into 50 mL conical flasl<:s 
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and 5 mL of 1,0 M diethylamine was added into the flasks. The flasks 
were kept in a water bath thermostated at 80 ± 2°C for 20-25 minutes, 
After complete hydrolysis, the contents of the flasks were cooied at 
room temperature followed by addition of 1.2 mL of 1.0 M hydrochloric 
acid, 5 mL carbon tetrachloride and 3 mL of 0.01 M potassium iodate. 
The contents were shaken vigorously till a deep red-violet colour is 
formed in the non-aqueous layer. Then followed the recommended 
procedure I. 
Assay of capsules 
No pre-analysis modifications were required for the assay of 
drugs in capsules. Contents of 15-20 capsules were mixed and an 
appropriate amount of this mixture, equivalent to 100 mg of drug, was 
weighed and dissolved in 50 mL water with shaking for 30 minutes to 
ensure a homogenous solution. The residues were filtered off and 
filtrate was collected in 100 mL volumetric flask and diluted upto the 
mark. Follow the aforesaid procedures. 
Assay of vials 
The contents of two vials of penicillin were mixed well and an 
appropriate amount was weighed accurately that corresponds to 
100 mg of the penicillin. This was transferred into a 100 mL standard 
volumetric flask, dissolved and diluted upto the mark with water. 
Procedures described above were followed. 
RESULTS AND DISCUSSION 
Preliminary studies were carried out to determine the ideal 
conditions for the hydrolysis of penicillins and development of 
maximum colour of the reaction product. The effect of experimental 
conditions, such as addition of appropriate amount of diethylamine, 
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hydrochloric acid and potassium iodate were studied by varying one 
parannieter at a time in recommended procedure I I . 
Effect of heating of hydrolysis 
In order to ascertain the optimum conditions of heating time and 
temperature, the drug samples were hydrolysed at different reaction 
time [Table 2.2, Fig. 2.3] and temperatures [Table 2.3, Fig. 2.4]. It was 
found that for complete hydrolysis 20 minutes of heating at 80 ± 2°C is 
sufficient for complete hydrolysis. 
Effect of diethylamine 
Amount of diethylamine was varied from 1 mL to 8 mL. From the 
graph it is evident that for complete hydrolysis of penicillins 5 mL of 
1.0 M diethylamine was required [Table 2.4, Fig. 2.5]. 
Effect of hydrochloric acid 
After complete hydrolysis of the penicillins, different volumes of 
acid were added to each flask. Maximum absorbance was recorded 
from 1.2 mL of the acid [Table 2.5, Fig. 2.6]. 
Effect of potassium iodate 
Different volumes of 0.01 M iodate were added to each flask 
after hydrolysis. Maximum absorbance was observed from, 2.5 niL of 
iodate [Table 2.6, Fig. 2.7]. 
Absorption spectra 
The spectra recorded under specified conditions of the assay 
exhibited a maximum at 520 nm [Fig. 2.2], 
Several aliphatic and aromatic amines were tried to hydrolyse the 
penicillins, to obtained the degraded products [Table 2.7]. On the basis 
of their solubility in water and KB values, the results with diethylamine 
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were found to be encouraging. A steady slow production of conjugate 
OH ions (observed and theoretical values 1.7 x 10"^  and 3.0 x 10"'' 
moles lit"^  respectively) are obtained as a result of its (diethylamine) 
hydrolysis. These OH ions are sufficient enough to hydrolyse the 
penicillins into their degraded products which are quantitatively oxidized 
to sulphur derivatives by potassium iodate in dilute acid. A red-violet 
colour in non-aqueous layer is obtained due to the reduction of 
potassium iodate into free iodine. The other aliphatic and aromatic 
amines failed to hydrolyse penicillins due to feebly production of 
conjugate OH ions (low KB values / low solubility) as a result the non-
aqueous layer remains colourless. 
The mechanism of penicillin degradation in 1.0 M diethylamine 
(at 80°C for 20 min) can be visualized in the light of thin layer 
chromatography, ultraviolet and infrared spectroscopic studies and 
molar stoichiometric ratio of iodate to penicillins. The possible 
degradation pathways have been illustrated in Fig. 2.1. 
Thin layer chromatography and spectrophotometric studies 
The major hydrolysis product can be suggested as penicilloic acid 
[Ib(i)] on the basis of results obtaind by TLC (Rf 0.52, for a solvent 
system made v/v 66% n-butanol, 17% glacial acetic acid, 17% water). 
Earlier studies (24) establishes the presence of Ib(i) with Rf 0.46 in the 
pH range 4.0 to 13.0 for the same solvent system. The difference in Rf 
values (0.06) may be attributed to a long range of pH (acidic to 
alkaline) where as in the recommended procedure the hydrolysis is 
carried out in a single stage alkaline medium (pH ~ 12.25). The 
hydrolysed product showed a X^ax at 245 nm at reaction time of 20 min 
at 80°C. This atthbutes to the existence of one of the three species 
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Ib(i), Ib(ii) or Ib(iii). On extending the time of hydrolysis for another 12 
hrs no appreciable shift in >.max (246 nm) was observed. This clearly 
suggests the absence of 4-hydroxymethylene oxazolone [contrast to 
the result in 0.1 M NaOH, [OH"] = 1.0 x 10"^  moles lit'^ wherein the 
presence of 4-hydroxymethylene oxazolone was established (25)]. This 
clearly suggests that the ultimate degraded products of hydrolysis with 
1.0 M diethylamine ([OH"] = 1.7 x 10"^  moles lit'^) are Ib(i), Ib(ii) and 
Ib(iii). Further the oxidation of hydrolysed products is restricted to 
sulphoxide [whereas in O.IM NaOH, the ultimate oxidation products are 
suloxide followed by sulphonic acid (25)]. 
IR studies 
For infrared studies four spectra were recorded, (i) Spectrumi-A; 
pure amoxycillin [Fig. 2^c(A)], (ii) Spectrum-B: hydrolysed products of 
amoxycillin [Fig. 2JO{B)], (iii) Spectrum-C: hydrolysed product of 
amoxycillin treated with dilute hydrochloric acid followed by titration 
with potassium iodate till a red-violet colour is obtained [Fig. 2.}0{Q], 
and (iv) Spectrum-D; diethylamine in aqueous solution [Fig. 2.|(\D)]. 
Comparison of spectrum-A and B shows that some bands of 
spectrum-A are missing and some new bands have been formed in 
spectrum-B. The broad flat portion (3750-3150 cm'^) remains same in 
spectra A,B,C and D which can be attributed to primar/ aliphatic amine, 
>N-H, carboxyl and -S-H group. 
Missing and formation of bands 
The bands (spectrum-A) in the range 1850-1705 cm^ and 1500 
800 cm" were missing. New bands (spectrum-B) were formed m the 
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range 1690-1590 cm'\ 760-730 cm"^  and 730-650 cm \ 1 he 
characteristic band of carbonyl group (1825 cm'^ ) of thiazolidine, esters 
(1748 cm"^ ) were completely swept out. The group frequencies of C - 0 
stretching and 0 - H deformation (1440-1395 cm'^) of thiazolidine were 
also missing. The other groups in the range 1395-800 cm'^  were 
completely hydrolysed without formation of any peak. 
A broad band in the range 1690-1590 cm"^  was formed in 
spectrum-B. This shows the presence of amide linkage. The band for 
carboxyl group of primary amide (1613 cm"^), and secondary amide 
(1685-1510 cm'^ ) are clear in spectrum-B. The weak peak at 660 cm"^  
suggests the presence of disulfide -S-S- and C-S- (705-570 cm"^), 
and another band at 740 cm'^  may be attributed to >S = 0, C-S-0 
groups of sulphoxide. 
The Spectrum-C: A broad weak band in the range 790-720 cm ^ 
establishes the presence of sulphoxide which was obtained as an 
oxidative product after redox titration. 
The recommended procedure-I describes simultaneous 
volumetric and spectrophotometric determination of penicillins 
(ampicillin, amoxycillin and carbenicillin). The hydrolysed products of 
penicillins were titrated against an oxidizing agent, potassium iodate, in 
dilute acid to provide conducive environment of H;O (pH ~ 1.4) for 
quantitative titration of degraded products against potassium iodate 
The deep red-violet coloured product was extracted in CCU at the 
equivalence point, The sulfur derivatives as, -C-S-C- [Ib(i) & Ibj i ) ] and 
-S-H-group [Ib(iii)] contained as hydrolysed products of penicillins were 
quantitatively oxidized to sulphoxide. The reaction can be summiarized 
as below, 
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0 0 
2HS - R + 2H2O - ^ — • R_ s - S - R + 6H"^+ 6e" X2 Step 
IO3 + CI + 6H + 4e- ICI + 3H3O5 X 3 
In the first step reaction a quantitative oxidation of thiol grojp into 
sulphoxide by reduction of 10; to ICI takes place which may be 
attributed to the reaction at equivalence point without any colour 
change. This shows theoretical stoichiometric value to be 2 mole of 
thiol group and 3 mole of iodate (1:1.5) which is inconsistent to the 
experimental value 1:2 (26). However, to make the endpoint visible, 
more iodate is required. Iodate is reduced to iodine monochloride and 
finally to free iodine. The reaction involved can be summarized as. 
i(T3 + cr+ SH'^- 4 ^ reduction > ICI + 3H2O 
IP I di^ soc[atjon + p j 
1% HoO MloLysis^^ HOI 4- H" 
_ + 
step II 
5H01 oyer-ConsumptLon^iqdate^ 2I2 + I0"3 + H + 2H2O J 
In step II over consumption of iodate (27) takes place as a result 
the mole ratio of iodate increases from 1.5 to 2.0 which is consistent 
with the experimentally observed stoichiometry of 1 mole of thiol to 2 
moles of iodate. The equivalence point can be detected as a red-violet 
colour in non-aqueous layer due to the formation of free iodine. It is 
important to note here that further addition of iodate beyond the end 
point doesn't decolourises the medium. A more precise depiction of 
over consumption of 10; at the end point has been diagrammatically 
represented below: 
IO3 (+5) in dilute HCI 
10^ + c r + 6H*+ 4S- • ICI + 3H2O 
^ , , ,• . , Observed end pt. T I C I { + 1 ) _ 
Quantitative oxidation JT. ^ ^ ^ ^_ / _ . •More IO3 involved in the svstem 
of penicillin (Penicillin : 10^-1:1.5) 
Increases 
True end pt. 
Over consumption of IO3 
lp(0) Penicillin : I O 3 - 1:2 -« 
Step I: Dissociation and Hydrolysis 
Step I I : The presence of HOI indicates an over consumption of 10-, resulting free iodine (true end 
point). 
21O3 + 12H + lOe I2 + 6H2O E ° = 1.19V 
A quantitative oxidation-reduction system can be established and 
understood from the following illustration. The electrode potential (E )^ 
of iodate in dilute hydrochloric acid (1.19 V) is less than that of m 
Andrews titration (1.23 V), i.e. in strong hydrochloric acid. But it, E° 
1,19 V, is still high enough to oxidized degraded products but not as 
high as to have any effect on free iodine. 
In contrast, a strong hydrochloric acid is required in Andrews 
titration (28) for reduction of iodate to iodine monochloride (ICI,; 
complex. 
10-^ • 6 H ' '-2 0' • ^e' ->IC\2 + 3 H 2 O 1.23V 
During titration with reducing agent i.e. penicillin, further reduction of 
iCi causes the existence of free iodine as. 
2 ICI, -i 2 e ->I- - 4 CI E° = 1.06V 
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When the reducing agent has been consumed completely, the free 
iodine is titrated to form iodine monochloride resulting in the end point 
with disappearance of last tinge of free iodine (A point of difference in 
the present method in step II). 
21, + 1O3 f6H* + i o c r -> 51CI2 +3H2O 
The above mechanism of Andrews titration has been explaint^d ifi a 
lucid way by the following diagram, 
IO3 (+5) in strong HCI (3.0-9.0 M) 
IOJ+ 2Cr+ 6H + 4e"^ ^ •ICI2 + 3H2O E° = 1.23 
Penicillin completely ^-^-^^ P°' 
consumed 
nt 
V 1CI2(+1) 
In the presence of penicilin 
2ICl2 + 2e" 
-»-l2 + 4CI 
l2(0), 2l2 + IO^+6H+1 OCI 
1.06V 
->51Cl2+ 3H2O 
Free iodine is titrated against lOo resulting in disappearence of the 
colour at the end point as given below 
2I2+ I 0 ^ + 6 H + 10CI-
(Red-violet) 
-•5ICI2 + 3H2O 
(Colourless) 
The recommended miethod can be applied specially for drugs 
having sulphur derivatives which can be oxidized by mild oxidizing 
agents (27). The half reaction of iodate in dilute acidic condition (29) 
with E° can be proposed as, 
21O3 -12H- -lOe ~>l, +6H2O 1.19V 
The precision of the method was determined by applying 10 
replicates of 1.0 mg of pure penicillins. The mean % recovery, and 
relative standard deviation (%) at this concentration level have been 
reported in Table 2.8. The recommended methods have been applied 
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successfully in determination of ampicillin, amoxycillin and carbenicillin 
in pure form [Table 2.9 (A), (B) and (C), and 2.10 (A), (B) and (C)] and 
in pharmaceutical fomiulations [Table 2.11 (A), (B) and (C)]. The 
recommended methods were compared with the reference (12) 
method. The results of both the methods was compared statistically 
[Table 2,11 (A), (B), and (C)] by the student's Y test and vadance 
ratio, T' The calculated T' value did not exceed the theoretical valu-.^  
which indicates that there is no significant difference between the two 
mean recoveries. The variance ratio, F, shows that there is no 
significant difference between the precision of the two methods. 
Statistical treatment of the results obtained by the recommendeci 
methods has been reported in Table 2.12 (A) and (B). 
The effect of the interfering substances in determination o*' 
penicillins was studied and the maximum tolerance of these substances 
for 1.0 mg of penicillins have been reported in Table 2.13. 
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Table 2.1: Structural formula of ampicillin^ amoxycillin and 
carbenicillin 
RCONH-
H H CHr 
o^ 
-N-
^CH. 
Generic Name 
Ampicillin 
/ \ 
H CO2H 
NH. 
Amoxycillin HO- W // 
D 
-CH-
NH. 
Carbenicillin W // -CH-
CO2H 
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Table 2.2: Effect of heating time (in minutes) in a thermostated 
water bath at 80 ± 2°C on absorbance in given 
amount of penicillins (200 jig mL"^ ) 
Time (Min) 
"'5 
10 
15 
20 
25 
30 
40 
• 
Ampicillin 
0.245 
0.345 
0.376 
0.382 
0.384 
0.384 
0.384 
Absorbance 
Amoxycillin 
0.225 
0.323 
0.350 
0.358 
0.360 
0.360 
0.360 
Carbenicillin 
0.198 
0.291 
0.314 
0.323 
0.325 
0.326 
0.326 
Table 2.3: Effect of variation of temperature on absorbance in 
given amount of penicillins (200 [ig mL"^) 
Temperature 
(°C) 
50 
60 
70 
80 
90 
95 
100 
Ampicillin 
0.322 
0.342 
0.362 
0.383 
0.384 
0.384 
0.378 
Absorbance 
Amoxycillin 
0.293 
0.321 
0.348 
0.362 
0.362 
0.362 
0.355 
Carbenicillin 
0.271 
0.298 
0.317 
0.325 
0.326 
0,326 
0.321 
Table 2.4: Effect of different volume of diethylamine on 
absorbance in given amount of penicillins 
(200 ^g mL"^) 
DEA 
(mL) 
1 
2 
3 
4 
5 
6 
7 
8 
PH* 
11.5 
12.15 
12.20 
12.25 
12.25 
12.30 
12.30 
12.30 
Absorbance 
Ampicillin 
0.262 
0.335 
0.364 
0.380 
0.384 
0.386 
0.386 
0.388 
Amoxycillin 
0.228 
0.298 
0.330 
0.351 
0.360 
0.363 
0.363 
0.364 
Carbenicillin 
0.202 
0.257 
0.292 
0.311 
0.322 
0.326 
0.326 
0.326 
* pH recorded before hydrolysis of penicillin 
Table 2.5: Effect of different volume of acid on absorbance in 
given amount of penicillns (200 )ig mL"^) 
HCI 
(mL) 
0.4 
0.6 
0.8 
1.0 
1.2 
1.4 
1.6 
1.8 
PH* 
2.85 
2.05 
1.85 
1.50 
1.40 
1.30 
1.20 
1.10 
Absorbance 
Ampicillin 
0.326 
0.352 
0.372 
0.384 
0.386 
0.386 
0.386 
0.383 
Amoxycillin 
0.298 
0.327 
0.348 
0.358 
0.360 
0.360 
0.360 
0.359 
Carbenicillin 
0.282 
0.305 
0.318 
0.324 
0.326 
0.326 
0.326 
0.323 
pH recorded after hydrolysis penicillin followed by addition of acid. 
Table 2.6: Effect of different volume of potassium iodate 
(acidic solution) on absorbance in given amount of 
penicillins (400 |ig mL"^ ) 
Volume 
KI03(mL) 
0.5 
1.0 
1.5 
2,0 
2.5 
3.0 
3.5 
4.0 
Absorbance 
Ampicillin 
0.359 
0.570 
0.685 
0.740 
0.778 
0.780 
0.780 
0.782 
Amoxycillin 
0.302 
0.520 
0.632 
0.692 
0.722 
0.726 
0.726 
0.726 
Carbenicillin 
0.289 
0.472 
0.570 
0.622 
0.648 
0.652 
0.652 
0.652 
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Table 2.7: Hydrolysis of penicillins by various aliphatic and 
aromatic amines and their response in the non-
aqueous layer after treating with dilute 
hydrochloric acid and potassium iodate 
Amines 
Anilline 
4-nitroanilline 
Ethanolaniine 
Diethylene 
triamine 
Diphenyl amine 
Diethyl amine 
KB 
4.2 X 10"'° 
1,0 X 10"-' 
6.0 X 10'^  
9.6 X 10"" 
Solubility, 
gm/lOOgm H2O 
3.7 
d.OS 
Insoluble 
V. soluble 
1 
Colour in non-
aqueous layer 
Colourless 
Colourless 
Colourless 
Colourless 
Colourless 
Red-violet colour 
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A- Degraded hydrolysed products; single stage hydrolysis of pen cillin', in 
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Fig. 2.1: The possible degradation pathways of penicillin at 
pH~12.25 followed by oxidation with iodate ions in dilute 
hydrochloric acid (pH ~ 1.4) 
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CHAPTER THREE 
SPECTROPHOTOMETRIC DETERMINATION OF 
AMPICILL IN, AMOXYCILLIN A N D CARBENICILL IN USING 
FOLIN-CLOCALTEU PHENOL REAGENT 
L 
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INTRODUCTION 
A number of modified analytical procedures utilizing Floin-
Ciocalteu phenol reagent have been reported in the literature. Despite 
its great sensitivity and simplicity, its use in the early twentieth century 
was restricted mainly in biochemical studies. The reagent has 
considerable merit for certain applications but that its peculiarities and 
limitations need to be understood for its fulliest exploitation. It is 
therefore recommended that the effect in the variation of pH, time of 
reaction and concentration of reactant, and permissible levels of 
reagent must be taken into account before its use for determination of 
substances with reducing properties. 
A simple spectrophotometric method (1) has been developed for 
the determination of certain cephalosporin drugs such as cefotaximie 
sodium, cefadroxil and cafaclor. The method is based on the formation 
of blue coloured chromogen, when the drug solution reacts witt F-olin -
Ciocalteu reagent in the presence of sodium carbonate solution. The 
chromogens formed have absorption maxima at 675 nm, 672 nm and 
672 nm respectively. Chromogen is stable for 45 minutes. In another 
spectrophotometric method (2) the reagent has been used for the 
determination of six drugs namely oxymetazoline, isoxuprine, 
orciprenaline, pholedrine, vitamin K^ dibutyrate and rutin. The reaction 
between the reagent and the drugs in basic medium resulted a blue 
coloured complex having Xmax at 650 nm. Some diuretics (3) have been 
determined in pharmaceuticals by spectrophotometry using Folin-
Ciocalteu reagent. The absorbance at the corresponding Xmax between 
740 and 770 nm was measured. 
A spectrophotometric method for the determination of 
astemizole (4) in pure form and in pharmaceutical formulations has 
103 
been described. It is based on the reduction of Folin-Ciocalteu reagent 
in basic medium with Xma-x at 720 nm, The application of Folin-Ciocalteu 
reagent has been extended to the determination of salbutamol (5), It 
utilizes the reduction of Folin-Ciocalteu reagent by phenolic group of 
the drug and monitoring the absorbance of the resulted blue complex 
at 760 nm. 
Folin-Ciocalteu reagent has been widely applied ""or the 
determination of a number of compounds acting as reductants (6), as 
well as to quantify phenol morphine in the presence of its methyl ether 
codeine (7). 
In the present method reaction mixture of penicillins (ampicillin, 
amoxycillin and carbenicillin) and Folin-Ciocalteu reagent was heated in 
a thermostated water bath at 95+ 2°C for 30 minutes. The resulted blue 
colour was detected at Xmax 790 nm, 810 nm and 780 nm respectively 
for ampicillin, amoxycillin and carbenicillin. Comparision of the 
recommended method with the reference method produced satisfactory 
results. 
EXPERIMENTAL 
Apparatus 
All the absorbance were measured on Spectronic 20D^ (Milton 
Roy, USA) spectrophotometer with 1 cm matched glass cells. A 
thermostated water bath (NSW, India) and an Elico model LMOT pH 
meter were used. 
Reagents 
Commercially available Folin-Ciocalteu phenol reagent, 2.0 N with 
respect to acid, (Merck, Germany) was used. To prepare 0.1 N reagent 
solution, it was diluted 20 folds with distilled water. 
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Preparation of standard drug solution 
Stock solutions of ampicillin, amoxycillin and carbenicillin were 
prepared by dissolving 50 mg of pure and standard penicillin (Sigma 
Chem. Co., USA) in 100 mL standard volumetric flask (for ampicillin) 
and in 50 mL standard volumetric flask (for amoxycillin and 
carbenicillin) and diluted to volume with distilled water. This provides a 
final concentration of 0.5 mg mL"^  for ampicillin and 1.0 mg mL'^  for 
amoxycillin and carbenicillin. 
General procedure 
Into a series of 50 mL conical flasks containing aliquots of 
ampicillin (0.2 - 0.8 mg), amoxycillin (0.25 - 1.0 mg) and carbenicillin 
(0.3 - 1.5 mg), 15 mL of Folin-Ciocalteu reagent was added. The 
contents were thoroughly mixed and kept in a thermostated water bath 
at 95 ± 2°C for 30 minutes. The flasks were taken out and cooled at 
room temperature ( -25°C). Contents were transferred carefully into 
25 mL-standard volumetric flask, and diluted upto the mark with 
distilled water. The absorbance of the resulted blue colour was 
measured at 790 nm, 810 nm and 780 nm for ampicillin, amoxycillin 
and carbenicillin respectively against a reagent blank. 
Assay of vials 
The powder contents of two vials were mixed well and an 
amount equivalent to 50 mg of penicillin was transferred into a 50 ml 
standard volumetric flask (for amoxycillin and carbenicillin) or 100 mL 
standard volumetric flask (for ampicillin), dissolved and diluted upto the 
mark with distilled water. Follow the general procedure recommended 
above. 
Assay of capsules 
A quantity, equivalent to 500 mg of penicillin, of mixed contents 
of 20 capsules was accurately weighed and transferred into a 100 mL 
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standard volumetric flask and dissolved in methanol (Analytical grade) 
with vigorous shaking and diluted upto the mark with the same solvent. 
Contents of the flask were filtered and 10 mL of the filtrate (containing 
50 mg of the penicillin) was pipetted into 100 mL standard volumetric 
flask (for ampicillin) and 50 mL standard volumetric flask (for 
amoxycillin and carbenicillin). Solvent was evaporated on a hot water 
bath and the dry residue was treated as described in preparation of 
standard drug solution followed by the general procedure. 
RESULTS AND DISCUSSION 
Optimum conditions relating to stability and intensity for 
production of maximum intensity of colour, variation of temperature 
and effect of adding volumies of Folin-Ciocalteaus reagent were studied 
as follows; 
Effect of reaction time on absorbance at specified temperature 
The reaction was carried out at different temperatures 
[Table 3.1, Fig. 3.2] using thermostated water bath for a period ranging 
from 5 minutes to 40 minutes [Table 3.2, Fig. 3.3]. Heating for 30 
minutes at 95 ± 2°C was found to be the most suitable condition for 
development of maximum intensity of colour. 
Effect of Folin - Ciocalteu reagent 
The effect of varying volumes of 5% v/v Folin- Ciocalteu reagent 
on the absorbance was studied. It was found that the optimum volume 
of the reagent to produce maximum absorbance of the coloured 
product is 15 mL [Table 3.3, Fig. 3.4]. 
Absorption spectra 
Absorption spectra for ampicillin, amoxycillin and carbenicillin was 
recorded with Arnax 790 nm, 810 nm and 780 nm respectively [Fig. 3.1]. 
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Hydrolysis of penicillins and their derivatives both in acidic and 
basic range has been reported (8) to study the different mechanistic 
pathways of oxidative products. It was observed that the formation of 
different hydrolysed products depends upon the specified pH or the 
range of pH. 
In earlier studies application of Folin-Ciocalteu reagent has been 
recominended in alkaline solution by adding sodium hydroxide solution 
or sodium carbonate solution or using a buffer solution to provide a 
pH^lO. This pH provides a conducive environment for the development 
of maximum intensity of colour after the reduction of the reagent, 
In the present study we have used Folin - Ciocalteu reagent in its 
present form having a pH - 2.25. The action of the reagent is two fold. 
Firstly, it brings about the acid hydrolysis of penicillins to produce 
different hydrolysed products. In the second step the hydrolysed 
products undergo oxidation followed by the reduction of Folin-Ciocalteu 
reagent resulting the formation of a stable blue coloured complex {Xm,., 
790 nm, 810 nm and 780 nm for ampicillin, amoxycillin and carb(!nicilliii 
respectively) in the form of heteropolyanions of Mo(VI) and W(VI) (9). 
The phosphomolybdate (providing characteristic yellow colour to 
the Folin - Ciocalteu reagent) and phosphotungustate can be reversibly 
reduced by the addition of one to six electrons per anion to give the 
heteropoly blues, a generic name derived from their intense 
colouration. These blues can be classified as mixed - valence 
complexes containing Mo(V) and Mo(VI), or W(V) and W(VI). The 
intense, fairly broad band observed in the visible/near IR is typical of 
these complexes and has been attributed to intervalence charge-
transfer bands between Mo(V) and Mo(VI) via an oxo bridge, or to d-d 
bands for Mo(V) (9,10). The large values of molar absorptivity obtained 
is consistent with those usually observed for d-d transition (9,10). In 
the present study the apparent molar absorptivities for ampicillin. 
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amoxycillin and carbenicillin have been obtained as 1.48 x 10'', 
1.17x10"^  and 6.79 x 10^ lit mol'^ cm"^  respectively. 
The precision of the recommended method was checked by 
applying 10 replicates of 0.5 mg of ampicillin and amoxycillin, and 
1.0 mg of carbenicillin. The results have been summarized in Table 3.4. 
The recommended method has been successfully applied for 
determination of ampicillin [Table 3.5, Fig. 3.5], amoxycillin [Table 3.6, 
Fig. 3.6] and carbenicillin [Table 3.7, Fig. 3.7] in pure form and in 
pharmaceutical formulations [Table 3.8]. The results of the proposed 
method have been compared [Table 3.8] with the reference method 
(11) and no significant difference was observed between the mean 
recoveries of the two methods as the calculated 't' value is smaller than 
the tabulated 't' value. While no significant difference in the precision of 
the two methods was obsen/ed as Fcaicuiated is smaller than the Ftabuiated • 
Statistical treatment of the results obtained by the recommended 
method has been summarized in Table 3.9. 
The effect of the interfering substances for determination of 
penicillins has been studied [Table 3.10]. 
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Table 3.1: Effect of temperature on absorbance 
Temp °C 
50 
GO 
70 
80 
90 
95 
100 
Ampicillin 
0.478 
0.640 
0.796 
0.845 
0.865 
0.865 
0.865 
Absorbance 
Amoxycillin 
0.296 
0.402 
0.528 
0.596 
0.640 
0.640 
0.636 
Carbenicillin 
0.12 
0.163 
0.260 
0.358 
0.392 
0.392 
0.386 
Table 3.2: Effect of reaction time (at 95 ± 2°C) on absorbcince 
Reaction Time 
(Min) 
5 
10 
15 
20 
25 
30 
35 
40 
Ampicillin 
0.146 
0.342 
0.602 
0.772 
0.835 
0.860 
0.860 
0,860 
Absorbance 
Amoxycillin 
0.109 
0.279 
0.422 
0.542 
0.605 
0.640 
0.640 
0.640 
Carbenicillin 
0.086 
0.156 
0.228 
0.290 
0.328 
0.332 
0.332 
0.332 
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Table 3.3: Effect of volume of Folln-Ciocalteu reagent on 
absorbance 
F.C. Reagent 
( m l ) 
2 
4 
6 
8 
10 
12 
13 
14 
15 
16 
Ampicillin 
0.406 
0.760 
0.970 
1.130 
1.250 
1.320 
1.370 
1.400 
1.400 
1.400 
Absorbance 
Amoxycillin 
0.244 
0.422 
0.571 
0.702 
0.822 
0.940 
0.9/5 
1.05 
1.100 
1.100 
Carbenicillin 
0.140 
0.326 
0.441 
0.540 
0.640 
0.724 
0.752 
0.760 
0.760 
760 
Table 3.4: Precision testing of the proposed method for 
spectrophotometric determination of penicillins 
Penicillins 
Ampicillin 
Amoxycillin 
Carbenicillin 
Amount Taken 
(mg) 
0.500 
0.500 
1.00 
Amount Found 
(mg) 
0.501 
0,503 
1.00 
% Recovery 
100.20 
100.60 
100.00 
RSD* 
( % ) 
0.70 
0.45 
0.35 
* 10 replicate of 0.5 mg of ampicillin and amoxycillin, and 1.0 mg of carbenicillin. 
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Table 3.10: Maximum tolerance amount of excipients in 
the determination of penicillins (0.5 mg) 
Excipients added 
Lactose 
Fructose 
Glucose 
Sucrose 
Calcium carbonate 
Starch 
Maximum tolarance (mg) 
80.90 
25.30 
28.50 
72.20 
4.2 
2.20 
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• T I 
C H A P T E R FOUR 
SPECTROPHOTOMETRIC DETERMINATION OF (I) 
CEFOTAXIME SODIUM A N D (ii) CHLORAMPHENICOL IN 
PURE FORM AND PHARMACEUTICAL PREPARATIONS 
USING TWO DIFFERENT PROCEDURES 
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INTRODUCTION 
Cefotaxime sodium, {sodium (6R,7R)-3-(acetyloxymethyl)-7-
[[(Z)-2-(2-aminothiazol-4-yl)-2-(methoxyimino) acetyl] amino]-8-oxo-5-
thJa-l-azabicyclo[4.2.0]oct-2-ene-2-carboxyiate} (1) is a semi synthetic 
tinird generation cephalosporin with broad spectrum antibiotic activity 
[Fig. 4.1(A)]. It is a penicillinase resistant antibiotic with high antibiosis, 
low toxicity, and low allerginity. It is extensively prescribed in infections 
caused by gram negative and gram positive bacteria and penicillin 
resistant staphylococei. Due to its high therapeutic value it is necessary 
to regulate its purity and potency. 
NOCHo 
^ H H 
N—T-C — CONH-
H2N' 
J ^:> /-n r -CH2OCOCH3 
G02Na 
Fig. 4.1 (A): Structural formula of cefotaxime sodium 
Several methods have been reported for the estimation of 
cefotaxime and other cephalosporins. British pharmacopoeia (1) 
prescribes liquid chromatography. In this method octadecylsilyl silica 
gel (stationary phase) and phosphate buffer of pH~7 and methanol 
(mobile phase) were used with a spectrophotometric detector at 
325 nm. United States pharmacopoeia (2) recommends high 
performance liquid chromatography for cefotaxime. Cefotaxime can be 
determined iodometrically after hydrolysis of p-lactam ring (3). This 
antibiotic has been identified along with other cephalosporins by thin 
layer chromatography on silanized silica gel with fluorescene indicator 
(4). Use of copper - pyridine complex has been reported for the assay 
of cefotaxime (5). Alkaline degradation of cefotaxime results in the 
formation of hydrogen sulphide which was reacted with N, N-dimethyl-
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p-phenylene diamine to form methylene blue (6). Mercury (II)-
imidazole reagent has been employed for the assay of cefotaxime in 
pharmaceutical preparations (7). Polarography has been used for 
determination of cefotaxime and other related antibiotics (8). In this 
method a pulse amplitude of 200 mV and supporting electrolyte of 
dimethylformamide or DMF-MeOH was used. Two polarographic waves 
were observed for cefotaxime. This antibiotic can be quantified by 
charge transfer complexation with chloranilic acid (9). Potentiometry 
has been used for the assay of cefotaxime (10). This method involves 
reaction of the drug with Hg(CI04)2 after previous reaction of the 
antibiotic with hydroxylamine. In a spectrophotometric method (11) the 
drug was hydrolysed in 5 molar hydrochloric acid and subsequently 
treated with oxidized haematoxyline and the resulted colour was 
recorded at 555nm. Reverse phase liquid chromatography has been 
used in determination of cefotaxime (12). In this method a C18 column 
(stationary phase) and MeOH-HzO-HOAc (mobile phase) were used with 
UV detector at 254nm. For spectrophotometric determination (13), 
cefotaxime was hydrolysed in alkaline medium. Hydrogen sulphide thus 
formed was treated with p-phenylenediamine-2 hydrochloric acid and 
the oxidized intermediate formed reacts with Fe(III) to give violet 
colour. Cefotaxime reacts with 4.62% sodium bicarbonate resulting in 
the formation of chromogen readable at 490 nm (14). A novel method 
for separation and identification of cefotaxime and other cephalosporins 
has been reported (15). Cephalosporins reacts with ammonium 
molybdate in dilute sulphuric acid medium resulting in the formation of 
blue colour (16). Cefotaxime has been determined quantitatively 
through oxidation with cerium (IV) and 1-chlorobenzotriazoIe (17). This 
antibiotic has been determined in pharmaceutical formulations by 
fluorescence quenching method (18). Reaction of the drug with 3-
methyl-2-benzothiazolinone hydrazone hydrochloride in presence of 
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ferric chloride results in the formation of blue colour (19). Other 
methods used for determination of cefotaxime includes high 
performance liquid chromatography (20), reversed phase liquid column 
chromatography (21), pyrolysis gas chromatography (22), immobilized 
enzyme reactor (23) and capillary electrophoresis (24). 
Chloramphenicol, {2,2-dichloro-/V - [(lR,2R)-2 - hydroxy - 1 -
hyroxymethyl - 2 - (4 - nitrophenyl) ethyl] acetamide} (1) is a broad 
spectrum antibiotic of widespread therapeutic application [Fig. 4.1(B)]. 
It is commonly used in treatment of infections where penicillins and 
tetracyclines have proved to be ineffective. 
NO2 
HO — C — H 
H — 0 — N H - C O —CHCL 
I ' 
CH2OH 
f\g.^^-jLi^)' Structure of chloramphenicol 
The assay of chloramphenicol has been, and is still the subject of 
much investigation. Most of the approaches are based on reactions for 
nitro group of the drug. However methods have also been reported 
involving reaction of the amide group or the decomposition products of 
chloramphenicol. The officially recommended methods in 
pharmacopoeias (1-2) for determining chloramphenicol rely on direct 
measurement of the absorbance at 278 nm or 276 nm of an aqueous 
solution of the drug. The most widely used spectrophotometric 
methods are based on reduction of the nitro group with acidic titanium 
(III), tin(II), zinc and aluminum followed by diazotisation and coupling 
(25). Red colour produced by the interaction of nitro-group with 
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dimethylformamide in acetone solution lias been used for quantification 
of ciiloramphenicol (26). This antibiotic on boiling with sodium 
hydroxide solution gives a yellow colour, due to the formation of 
sodium p-nitrophenoxide, which is detected spectrophotometrically 
(27). Oxidation of the base, produced by the acid hydrolysis of 
chloramphenicol, with iodate gives p-nitrobenzaldehyde which 
is determined colorimetrically (28). Hassan and Eldesouki (29) have 
determined chloramphenicol in phanriaceutical preparations by 
reduction of the NO2 group with cadmium in acid medium followed by 
determination of cadmium ions produced. 
Spectrophotometric determination of chloramphenicol involves its 
alkaline hydrolysis followed by reaction with 4-nitrosoantipyrine and the 
resulted colour was detected at 512 nm (30). Sulfonyl monohaloamine 
has been used for oxidimetric estimation of chloramphenicol (31). 
The reaction of chloramphenicol with sodium nitrite and p-naphthol 
gives red colour, which was studied by weisz ring oven 
method (32). Kinetics and mechanism of oxidation of chloramphenicol 
by N-bromosuccinimide has been studied (33). This method involves 
oxidation of the secondary alcoholic group of the drug to a ketone by 
the reagent. In a colorimetric determination of chloramphenicol the 
drug was reduced to corresponding hydroxamic acid. This was 
benzoylated and treated with ferric chloride solution to give different 
colours in different pH range (34). Nitritometric, iodometric and 
cuprimetric methods for determination of chloramphenicol have been 
reported (35). Chloramphenicol has been determined 
spectrophotometrically (36) by its hydrolysis with 4N NaOH at 100°C 
followed by neutralization with 4N HCI. The hydrolysed product was 
heated with ninhydrin-SnCb reagent producing colour with X^ax 570 
nm. Stability indicating full spectrum quantitation and HPLC have been 
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used for determination of alkali-induced degradation product of 
chloramphenicol (37). This antibiotic has been determined by coupling 
a continuous reduction system with an atomic-absorption spectrometer, 
which measures the release of cadmium or zinc ions (38). Micellar 
modified spectrophotometric determination of chloramphenicol has 
been reported (39). This method is based on reduction of the drug with 
tin (II) followed by diazotisation and coupling with the Bratton-Marshall 
reagent and the resulted colour was measured at 551 nm (for sodium 
dodecyl sulphate medium) and 558 nm (for non micellar medium). 
Morelli (40) has recommended a spectrophotometric method based on 
alkaline hydrolysis of chloramphenicol. The hydrolysed product was 
treated with ammonium molybdate in dilute sulphuric acid medium to 
give blue colour with X^ax 670 nm. Indirect acidimetric (41), 
argentimetric (42) and redox (43) titrations have been utilized for the 
determination of hydrolysis or decomposition products of 
chloramphenicol. Other methods for the assay of chloramphenicol 
includes electrochemical techniques (44), gas chromatography in 
combination with electron capture detector (45) and mass 
spectrometric detectors (46), parallel incident spectroelectro- chemical 
studies (47), flow injection biamperometric determination (48) and 
HPLC (49). 
In this chapter, two different methods for spectrophotometric 
determination of cefotaxime sodium and chloramphenicol have been 
described. The estimation of former is based on its reaction with 
ammonium metavanadate in presence of concentrated sulphuric acid, 
resulting the formation of a blue coloured complex {X^ax 760 nm). The 
later is determined prior to its reduction with HCI/Zn dust, followed by 
its reaction with sodium nitroprusside in presence of sodium hydroxide 
to produce green colour (:^ rnax 640 nm). 
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Both the methods were applied successfully in determination of 
pure cefotaxime sodium and chloramphenicol as well as in their 
pharmaceutical preparations. The results of the recommended methods 
were compared with the reference methods and found to be in good 
agreement. 
EXPERIMENTAL 
Apparatus 
A Spectronic 20D^ spectrophotometer (Milton Roy, USA) with 
matched 1.0 cm glass cells was used for absorbance measurements. A 
thermostated water both (NSW, India) was used for heating . 
Reagents 
Method -A 
0.5 M ammonium metavanddate solution was prepared by 
dissolving 5.85 gm of the reagent in 8 M sulphuric acid in 100 mL 
standard volumetric flask and diluted upto the mark with the same 
solvent. 
Method - B 
Aqueous solution of 0.1% (w/v) sodium nitroprusside was 
prepared by transferring 100 mg of the reagent in 100 mL standard 
volumetric flask, dissolved and diluted upto the mark with distilled 
water. 
Aqueous solution of 1.0 M sodium hydroxide. 
All reagent used were of Analytical grade. 
Preparation of standard drug solution 
Method - A 
An amount equivalent to 50 mg of pure and standard cefotaxime 
sodium (Sigma Chem. Co., USA) was accurately weighed and 
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transferred into a 50 mL standard volumetric flask, dissolved and 
diluted upto the mark with distilled water. This provides a stock solution 
with final concentration of 1.0 mg mL"^  of cefotaxime sodium. 
Method B 
50 mg of pure and standard chloramphenicol (Sigma Chem. Co., 
USA) was accurately weighed and transferred into a 100 mL standard 
volumetric flask and dissolved in 10 mL distilled water, followed by 50 
mg of zinc powder and 0.3 mL of concentrated hydrochloric acid. The 
flask was kept aside for 10 minutes, diluted upto the mark with distilled 
water and filtered. This provides the stock solution of reduced 
chloramphenicol with final concentration of 0.5 mg mL"\ The drug 
solution was stored in a dark container. 
General procedures 
Method A 
Into a series of test tubes containing aliquots of cefotaxime 
sodium (0.2-1.9 mg), 3 mL of 0.5 M ammonium metavanadate solution 
was added followed by 2.5 mL of concentrated sulphuric acid. The 
contents were thoroughly mixed and placed in a boiling water bath for 
30 minutes. The tubes were taken out and cooled at laboratory 
temperature ( ~ 25 ± 2°c). The contents were transferred carefully into 
10 mL standard volumetric flasks, diluted upto the mark with distilled 
water, mixed and cooled. The absorbance of the resulted blue colour 
was recorded at 760 nm against a blank prepared similarly omitting the 
drug. 
Method B 
Into a series of 10 mL standard volumetric flasks containing 
aliquots of reduced chloramphenicol, as described earlier, (0.2- 0.7mg), 
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1 mL of 0.1% sodium nitroprusside was added followed by 1 mL of 1 M 
sodium liydroxide. The flasks were allowed to stand for 30 minutes and 
diluted upto the mark. The absorbance of the resulted green colour was 
measured at 640 nm against a blank prepared similarly without the 
drug. 
Assay of vials 
Method A 
The powder contents of two vials of cefotaxime sodium were 
mixed well and an amount equivalent to 50 mg of the drug was 
weighed accurately and transferred into a 50 mL standard volumetric 
flask, dissolved and diluted upto the mark with distilled water. Follow 
the recommended Method-A as described In general procedure. 
Method - B 
The powder contents of two vials of chloramphenicol were mixed 
well and an amount equivalent to 50 mg of the drug was accurately 
weighed and transferred into a 100 mL standard volumetric flask and 
dissolved in 10 mL distilled water, followed by the preparation of the 
standard drug solution, as described in Method B. Assay was followed 
by the recommended Method-B as described in general procedure. 
Assay of capsules 
Method - B 
The powder contents of 20 capsules of chloramphenicol were 
mixed well and an amount equivalent to 500 mg of the drug was 
accurately weighed and transferred into a 100 mL standard volumetric 
flask, dissolved and diluted upto the mark with methanol (Analytical 
grade) and filtered. 10 mL of the filtrate, containing 50 mg of the drug, 
was pipetted into a 100 mL standard volumetric flask and evaporated 
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on a hot water bath. The dry residue was treated accordingly as 
described in the preparation of the standard drug solution (Method-B), 
followed by the general procedure (Method-B). 
Assay of ear drops 
Method - B 
The liquid contents of three bottles of chloramphenicol were 
mixed and a suitable volume, equivalent to 50 mg of the drug, was 
pipetted and transferred into a 100 mL standard volumetric flfisk and 
preparation of standard drug solution (Method-B) was followed. Assay 
was proceeded via general procedure (Method-B). 
RESULTS AND DISCUSSION 
In order to get optimum conditions related with stability, colour 
intensity, variation of temperature and reaction time, and addition of 
different volumes of reagents were studied. The details are given as 
under: 
Method - A 
Effect of different volumes of concentrated sulphuric acid 
Volume of concentrated sulphuric acid was varied from 0.5 - 3.0 
mL [Table 4.1, Fig. 4.3], 2 mL of the acid produced maximum intensity 
of colour. 
Effect of different volumes of ammonium metavanadate 
The optimum volume of ammonium metavanadate solution to 
produce maximum absorbance of the coloured product was found to be 
3 mL [Table 4.2, Fig. 4.4]. 
Effect of reaction time and temperature 
The reaction was carried out at different temperatures [Table 
4.3, Fig. 4.5] using thermostated water bath for the time periods 
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ranging from 5 nninutes to 40 minutes [Table 4.4., fig. 4.6]. The 
optimum time was found to be 30 minutes. 
Method B 
Effect of different volumes of sodium nitroprusside 
For the production of maximum intensity of colour 1 mL of 
sodium nitroprusside was found to be optimum [Table 4.5, Fig. 4.7] 
Effect of different volumes of sodium hydroxide 
1 mL sodium hydroxide was required for the development of 
maximum colour of the reaction product [Table 4.6, Fig. 4.8]. 
Effect of reaction time 
The reaction time was studied with a range from zero to 60 
minutes [Table 4.7, Fig. 4.9]. It was found that 30 minutes time is 
sufficient to produce maximum intensity of colour. 
Absorption spectra 
The absorption spectra of (A) cefotaxime sodium and (B) 
chloramphenicol, exhibited Xmax at 760nm [Fig. 4.2(A)] and 640 nm 
[Fig. 4.2(B)] respectively. 
Antibiotic cefotaxime sodium was hydrolysed in strong sulphuric 
acid resulting acid hydrolysed products. These products undergo 
oxidation in the presence of ammonium metavanadate (V) which is 
reduced to oxovanadium (IV) [VO "^^ ] ion resulting in the formation of 
blue colour (50). This vanadyl ion may react with cefotaxime sodium to 
produce a stable dark blue colour of [VO(cefotaxime)2] complex 
(?.max760 nm). 
In method-B, chloramphenicol was reduced with HCI/Zn dust into 
corresponding amine [Scheme 1] followed by reaction with alkaline 
sodium nitroprusside to produce green colour. 
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Q j , 3 z , , 6HC1 ^^^^^^^ [ Q l -3ZnCl2^2H20 
HO —C—H HO —C—H 
I I 
H —C—NH-CO—CHCU H —C—NH-CO-CHCU 
I 2 1 ' 
CH2OH CH2OH 
Scheme 1 
Sodium nitroprusside is a valuable reagent for the quantitative 
and qualitative determination of a wide variety of neucleophilic 
compounds. The reactivity of nitroprusside is based on its positive 
nitrosyl group, reacting with the neucleophilic species in alkaline 
medium (51). Generally, most of the formed addition compounds are 
highly coloured and stated to be used as the basis for 
spectrophotometric analysis. It may be suggested that nitroprusside ion 
[Fe(CN)5 No]^" undergoes decomposition, and reduction of iron (III) to 
iron (II) with the base leads to the formation of [Fe (CN)5 ^lOf'. 
Further, the study of the reaction by Job's method (52) suggests the 
molar stoichiometric ratio of chloramphenicol to nitroprusside as 4:1 
[Fig. 4.10]. 
Validity of the recommended methods was tested by applying 10 
replicates of 1.0 mg (for cefotaxime sodium) and 0.5 mg (for 
chloramphenicol). At these concentration levels, mean percent 
recovery, and relative standard deviation were found to be 99.98, and 
0.28 respectively (for cefotaxime sodium) and 100.14, and 0.19 
respectively (for chloramphenicol). As an additional demonstration of 
accuracy and recovery, experiments were performed by applying 
standard addition technique [Table 4.8 for cefataxime, and 4.9 for 
chloramphenicol]. 
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The recommended methods were applied successfully for 
determination of pure cefotaxime sodium [Table 4.10, Fig. 4.11] and its 
pharmacentical formulation [Table 4.11], end for determination of pure 
chloramphenicol [Table 4.12, Fig. 4.12] and its pharmacentical 
formulations [Table 4.13]. The results of the recommended methods 
have been compared with the reference methods [Table 4.11 and 4.13] 
using students 't' test and T'- variance ratio tests. The results shows 
that the recommended methods are in good agreement with the 
reference methods as the tabulated values of Y and T' are greater than 
the calculated values of Y and T'. Statistical treatment of the results 
obtained by the recommended methods have been summarized in 
[Tabled 4.14]. 
It is worth to note that addition of common of excipients results 
strong interferences in determination of cefotaxime (Method A). 
However, in Method B no such interferences were observed. The 
maximum tolerance amount of these excipients in given amount of 
chloremphenicol has been studied [Table 4.15]. 
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Table 4.1: Effect of different volume of concentrated sulphuric 
acid on absorbance for the given amount of 
cefotaxime sodium (100|ig mL"^) 
Volume of concentrated H2SO4 (mL) 
0.5 
1.0 
1.5 
2.0 
2.5 
3.0 
Absorbance 
0.292 
0.365 
0.422 
0.446 
0.446 
0.446 
Table 4.2: Effect of different volume of ammonium 
metavanadate on absorbance, for the given amount 
of cefotaxime sodium (100)ig mL"^) 
Volume of ammonium meta-
vanadate solution (mL) 
0.5 
1.0 
1.5 
2.0 
2.5 
3.0 
Absorbance 
0.308 
0.351 
0.398 
0.452 
0.452 
0.452 
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Table 4.3: Effect of temperature on absorbance, for the given 
amount of cefotaxime sodium (lOO^xg mL"^) 
Temperature ± 2°C 
50 
60 
70 
80 
90 
95 
100 
Absorbance 
0.345 
0.354 
0.365 
0.373 
0.385 
0.418 
0.456 
Table 4.4: Effect of reaction time (on boiling water-bath) on 
absorbance for the given amount of cefotaxime 
Sodium (lOO^g mL"^) 
Reaction Time (Minuts) 
5 
10 
15 
20 
25 
30 
35 
40 
Absorbance 
0.368 
0.396 
0.422 
0.450 
0.456 
0.457 
0.456 
0.456 
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Table 4.5: Effect of different volumes sodium nitroprusside on 
absorbance, in the given amount of 
chloramphenicol (SO i^g mL'^) 
Volume of sodium 
nitroprusside (mL) 
0.2 
0.4 
0.6 
0.8 
0.9 
1.0 
1.1 
Absorbance 
0.448 
0.506 
0.562 
0.610 
0.624 
0.624 
0.624 
Table 4.6: Effect of different volumes sodium hydroxide on 
absorbance in the given amount of 
chloramphenicol (50|ig mL'^) 
Volume of sodium hydroxide 
solution (mL) 
0.2 
0.4 
0.6 
0.8 
0.9 
1.0 
1.2 
Absorbance 
0.635 
0.648 
0.660 
0.670 
0.670 
0.670 
0.670 
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Table 4.7: Effect of reaction time on absorbance at laboratory 
temperature (~25 ± 2°C), in the given amount of 
chloramphenicol (50|ig mL"^ ) 
Reaction time (Minutes) 
5.0 
10.0 
15.0 
20.0 
25.0 
30.0 
40.0 
50.0 
60.0 
Absorbance 
0.121 
0.327 
0.485 
0.590 
0.605 
0.608 
0.608 
0.608 
0.610 
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Table 4.15: Maximum tolerance amount of excipients in the 
determination of 0.5 mg of chloramphenicol 
Excipients added 
Lactose 
Fructose 
Glucose 
Sucrose 
Calcium carbonate 
Starch 
Maximum tolerance (mg) 
7.3 
25.2 
28.9 
87.1 
3.2 
3.1 
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Fig. 4.2(B): Absorption spectrum of chloramphenicol 
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CHAPTER FIVE 
A SIMPLE KINETIC SPECTROPHOTOMETRIC METHOD FOR 
DETERMINATION OF KANAMYCIN MONOSULPHATE USING 
ACETYLACETONE-FORMALDEHYDE REAGENT IN N , N ' -
DIMETHYLFORMAMIDE MEDIUM 
^ J 
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INTRODUCTION 
Kanamycin monosulphate, {(9-3-amino-3-deoxy-a-D-glucopyra-
nosyl-(1^6)-C>-[6-amino-6-deoxy-a-D-glucopyranosyl-(1^4)]-2-deoxy-
D-streptaminesulphat} (1), is a polybasic aminoglycoside antibiotic. The 
structural formula is given below: 
NH2 
OH 
HOCH, 
O "0—1^ OH 
N — / N H 2 
. H2S04 
NH2 
Fig. 5.1: Structural formula of kanamycin monosulphate 
This antibiotic possess clinically useful broad spectrum activity 
against a variety of pathogenic microorganisms. However, it is capable 
of producing serious adverse effects such as renal damage, and 
auditory and vestibular dysfunction which makes it highly desirable to 
monitor levels of this antibiotic during therapy. Moreover, bulk drugs 
and pharmaceutical dosage forms described in official pharmacopoeias 
require potency and purity tests for certification. 
Several methods have been reported for their assay both in 
biological fluids and in final drugs based on various analytical 
techniques. The most commonly used and officially recommended 
methods for determining kanamycin potency are microbiological assay 
procedures (1-2). The assay of aminoglycoside antibiotics based on 
high performance liquid chromatography with pre-column (3) or post-
column (4) derivatization followed by fluorimetric or UV detection has 
been reported. Inouye and Ogawa (5) have used 0.9 x 39 cm column 
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filled with a strong anion exchange resin (200-400 mesh) for the 
separation of kanamycins. Tsuji and Robertson (6) have reported the 
use of gas chromatography for separation and detection of kanamycins. 
Aminoglycoside antibiotics have also been separated by two different 
solvent systems followed by spectrophotometric determination (7). This 
method utilizes the solvent system of chloroform-methanol-13 M 
NH4OH or ethylmethylketone-tert.butanol-13 M NH4OH for the 
separation, while ninhydrin was used for spectrophotometric 
determination. In a spectrophotometric method, kanamycin was 
reacted with 2,4,6-Trinitrobenzene-l-sulfonic acid in sodium 
bicarbonate solution. The contents were heated at 60°C for 15 nin and 
the intensity of the coloured product was measured at X^ax 420 nm (8). 
Reaction of Eu(III) metal with aminoglycosides has been studied (9). It 
was found that the sulphates of these antibiotics enhanced the 
absorbance. Use of 2,4-dinitrofluoro-benzene as the colouring reagent 
for spectrophotometric determination of kanamycin and other related 
antibiotics have been reported (10). Aminoglycoside antibiotics in 
injections have been determined spectrophotometrically {l^ax 356 nm) 
by Hantzsch reaction (11). Kanamycin has also been determined 
colorimetrically using tristimulus (Xio, Yio, Zio), and 3-dimensional 
coordinate method (12). Flow injection analysis of kanamycin by 
inhibition of the lucigenin-H202-Co^^ system in basic medium has 
been reported (13). Other methods for the assay of kanamycin 
include UV-visible spectrophotometry (14), fluorimetr/ (15), and 
radioenzymetry (16). 
The present method describes kinetic spectrophotometric 
determination of kanamycin monosulphate using acetylacetone-
formaldehyde reagent in N,N'-dimethylformamide solvent system which 
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shows two absorption maxima, one in UV region {Xmax 342 nm) and the 
other one in the visible region (Xmax 410 nm). Ail observations were 
made at ilmax 410 nm. The results of the proposed method were 
compared with reference method and both the methods were found to 
be in good agreement with each other. 
EXPERIMENTAL 
Apparatus 
Spectronic 20D^ spectrophotometer (Milton Roy, USA) with 
matched 1.0 cm glass cells, was used for absorption measurements. 
Reagents 
Acetylacetone-formaldehyde reagent was prepared by 
transferring 1.3 mL acetylacetone (s.d. fine Chem. Ltd., India) into a 
50 mL conical flask, followed by 5.0 mL formaldehyde (s.d. fine Chem. 
Ltd., India). The contents were placed in a boiling water bath for 1 min, 
cooled and transferred into a 50 mL standard volumetric flask and 
diluted upto the mark with N,N'-dimethylformamide (Qualigens, India). 
This gives a final concentration of 0.25 M acetylacetone and 1.306 M 
formaldehyde in solution. 
All reagents used were of analytical grade. 
Preparation of standard drug solution 
To get a stock solution of kanamycin of 1.0 mg mL"^  equivalent 
to molar concentration of 1.66 x 10"^  moles l i f\ 50 mg of pure and 
standard kanamycin monosulphate (Sigma Chem. Co., USA) was 
transferred into a 50 mL standard volumetric flask, dissolved and 
diluted upto the mark with distilled water. 
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General procedure 
Into a 10 mL standard volumetric flask, a suitable amount of 
kanamycin (0.6-1.6 mg equivalent to 9.98 x 10"^  - 2.66 x 10'^  moles 
lit"^) was transferred followed by 5 mL of acetylacetone-formaldehyde 
reagent and diluted upto the mark with 50% (v/v) aqueous N,N'-
dimethylformamide solution. The content were mixed and immediately 
transferred into the spectrophotometric cell. Absorbance was recorded 
as a function of time at X^ax 410 nm against a reagent blank. The slope 
of the tangent to the absorption-time curve was used a measure of the 
initial rate of reaction. The calibration curve was prepared by a plot of 
log RQ (initial rate of reaction) vs log C (molar concentration of 
kanamycin) [Table 5.3, Fig. 5.4], 
Assay of vials 
A quantity equivalent to 50 mg of kanamycin monosulphate was 
accurately weighed and transferred into a 50 mL standard volumetric 
flask, dissolved and diluted upto the mark to produce a final 
concentration of 1.66 x 10'^  moles lit"^ Assay was followed by general 
procedure. 
RESULTS AND DISCUSSION 
Effect of different volumes of acetylacetone-formaldehyde 
reagent on absorbance 
It was found that 5 mL of the reagent was sufficient to produce 
maximum intensity of the colour [Table 5.1, Fig. 5.3]. 
The absorption spectrum of the reaction product of kanamycin 
and acetylacetone-formaldehyde in N,N'-dimethlformamide medium 
shows characteristic maxima at 342 nm (e 5.05 x 10^ lit mole'^ cm'^ ) 
(UV) and 410 nm (e 3.67 x 10^ lit mole"^  cm" )^ (visible) [Fig. 5.2]. In 
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earlier studies (17) a quantitative determination of amikacin, kanamycin 
neomycin and tobramycin using acetylacetone-formaldehyde reagent 
has been reported. The reagent was prepared in a buffer solution of 
pH~ 2.5 containing 0.2 M each of acetic acid, boric acid and phosphoric 
acid in water. The absorption studies were made at X^ax 356 nm. 
The effect of various solvents in the studies of interaction of 
aromatic nitro compounds with bases has been studied. Attention was 
focused upon the spectral properties (different X^ax with respect to 
molar extinction coefficient) and equilibrium constant associated with 
the reaction product. The molar extinction coefficients at the position of 
the maximum absorbance depend markedly on the solvent employed in 
studying the reaction. The molar extinction coefficient of high band is 
found to be larger than that of low energy band (18). The effect of 
N,N'-dimethylformamide as a solvent showed an anology with these 
observations. 
The rate of reaction was found to be dependent on kanamycin 
concentration (keeping acetylacetone-formaldehyde reagent 
concentration constant). The rates were followed at room temperature 
(~25°C) with various concentrations of kanamycin in the range of 
60-160 ).Lg mL' [Table 5.2, Fig. 5.3]. 
The slope of the tangent to the absorption-time curve gives a 
direct measurement of the initial rate of reaction (Ro)(19). While the 
slope of the tangent to the log Ro vs log C (molar concentration of 
kanamycin) curve gives a direct measurement of order of reaction. The 
order of reaction with respect to kanamycin concentration was found to 
be one. Reaction rate was found to obey the following equation, 
Rate (R J = K" [ kanamycin ]" 
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Where K" is the rate constant and 'n' is the order of reaction. Taking 
logarithms of rates and concentrations of kanamycin, above equation is 
transformed into: 
log(rate) =; log— = logK' +nlog [kanamycin] 
Regression of log (rate) vs log [kanamycin] gave the regression 
equation [Table 5.3]: 
log Rn =2.757 + 1.096 logC 
Hence K =5.71x10^ min"^  and the reaction is first order (n = 1.096) 
with respect to kanamycin concentration. Correlation coefficient was 
found to be r= 0.9997. The calibration curve of log Ro vs log C showed 
a linear relationship over kanamycin concentration in the range of 
60-160 ).ig mL"\ 
The precision of the proposed kinetic method was checked by ten 
replicate determination of 100 ^g mL'^  kanamycin. Relative standard 
deviation and mean percent recovery at this concentration level were 
0.78% and 100.07% [Table 5.4]. The validity of the proposed kinetic 
method was checked by applying standard addition method and results 
have been reported in Table 5.5. 
The proposed method has been applied to the kanamycin 
determination in pure form [Table 5.3, Fig. 5.4] and in pharmaceutical 
preparations [Table 5.6]. The results obtained by the recommended 
method were compared with reference method (17). It was found that 
the proposed method is in good agreement with reference method. 
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Table 5.1: Effect of acetylacetone-formaldehyde reagent 
on absorbance 
Volume of reagent (mL) 
1 
2 
3 
4 
5 
6 
7 
Absorbance 
0.344, 
0.490 
0.572 
0.636 
0.650 
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Table 5.4: Precision testing of the proposed kinetic 
spectrophotometric method (amount of 
kanamycin taken = 100 |ig) 
Sample 
No. 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
Initial reaction rate 
(min-^ ) 
4.17 X 10"^  
4.20 X 10"^  
4.21 X 10"^  
4.17 X 10"^  
4.10 X 10'^  
4.20 X 10"^  
4.18 X 10"^  
4.16 X 10"^  
4.15 X 10"^  
4.12 X 10'^  
Amount of kanamycin found 
(ng mL-^ ) 
100.12 
100.87 
101.1 
99.93 
98.71 
100.87 
100.45 
99.93 
99.64 
99.09 
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Fig. 5.2: Absorption spectrum of kanamycin monosulphate 
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Fig. 5.3: Effect of different volumes of acetylacetone-
formaldehyde reagent on absorbance 
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Fig. 5.4: Plot of absorbance vs time : between kanamycin and 
acetylacetone-formaldehyde. Kanamycin concentrations 
are: (A) 9.98 x 10 "^  mol lit ''; (B) 1.33 x 10 * mol lit '^ ; 
(C) 1.66 X 10 ''^ mol lit ^ (D) 2.00 x 10* mol lit ^ (E) 
2.33 x 10 '" mol lit ^ (F) 2.66 x 10 * mol lit -\ Keeping 
reagents concentration constant. 
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Fig. 5.5: Calibration curve for kanamycin monosulphate : Plot of 
log Ro (initial rate of reaction) vs log C (molar 
concentration of kanamycin monosulphate 
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